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Abstract.
Exploitation of the asymmetric electron density at the crown of the
oxazolidinone [221] allowed for high diastereofacial selectivity when
converting the olefin to an epoxide. Regiocontrolled fragmentation of the
epoxide enabled us to introduce the three essential stereocentres of the target
alkaloid (-)-anisomycin [1] both contiguously and with the correct geometry.
Installation of the remaining aromatic appendage allowed us to complete the
molecular skeleton of the natural product; however, the synthetic step to
facilitate this addition reaction also compromised the chiral integrity of the C2
position. Whilst the desired bioactive alkaloid, (-)-anisomycin [1] was not
achieved upon completion of the synthesis, construction of the rare
stereoisomer, (-)-2-epi-anisomycin [274] in a 9.4% overall yield demonstrates
the routes future potential to deliver (-)-anisomycin [1].
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11. Introduction
21.1 Introduction to (-)-Anisomycin.
1.1.1. Structure and initial isolation.
The isolation of the monobasic pyrrolidine antibiotic (-)-anisomycin [1]
(Flagecidin®)1 was first reported in August 1954 by Sobin and Tanner at the
Pfizer Research Laboratories in New York1. It was isolated as long white
needle-like crystals by altering the pH of the fermentation medium filtrate of
two different Streptomyces species, Streptomyces griseolous and
Streptomyces roseochromogens, to pH 9.0 and extracting with methyl
isobutyl ketone, water and then chloroform1. (-)-Anisomycin [1] (Fig 1.1) was
also obtained from two further related Streptomyces species, No. 638 in 1974
by Ishida et al.2 and strain SA 3097 in 1993 by Hosoya et al3.
Figure 1.1: (-)-Anisomycin.
The alkaloid consists of a cyclic secondary amine core; a pyrrolidine ring
with asymmetric centres at C2, C3 and C4 in an R, S, and S configuration. A
second cyclic entity, an aromatic p-methoxybenzyl moiety is attached to C2
of the pyrrolidine via a methylene group and is arranged cis to the acetyl ester
of C3. The remaining appendage at C4 is a simple hydroxyl group and is set
trans relative to the acetoxy group.
(+)-Anisomycin [1a] and some of its various isomers4 have also been isolated
and characterised since Sobin and Tanner initially isolated (-)-anisomycin [1]
and are shown in Figure 1.2.
3Figure 1.2: Anisomycin stereoisomers.
Whilst most groups have concentrated on synthesising the biologically active
compound [1] or its enantiomer (+)-anisomycin [1a], and others have
conducted formal synthesis by reaching (-)-deacetyl anisomycin [4]; Park et
al.4 is the only group which has attempted the synthesis of the stereoisomers
of anisomycin and these will be discussed later in this report.
41.1.2. Biological properties.
(-)-Anisomycin [1] possesses strong and effective activity against certain
pathogenic protozoa1 particularly Trichomonas vaginitis and Endamoeba
histolytica, both in vitro and in vivo5, and has also been successful in the
clinical treatment of intestinal amebiasis6. It has been found to interfere with
peptide bond formation on eukaryotic ribosomes7 whereby the
transpeptidation step of protein synthesis is reversibly inhibited by the
binding of anisomycin [1] to the peptidyltranferase centre of the large
ribosomal subunit8,9.
(-)-Anisomycin [1] and a number of its derivatives have also found use as a
fungistatic agent in the eradication of bean mildew10 and as an inhibitor to
various other strains of phytopathogenic fungi found within the agricultural
environment11.
A study by Venrooij et al.12 reported that (-)-anisomycin’s [1] treatment of
Ehrlich ascites tumour cells suggested that the antibiotic was responsible for a
defect in the binding of native 60S subunits and a later report by Hosoya et
al.3 in 1993 concluded that the alkaloid and three derivatives (3097-B1, 3097-
B2 and 3097-C2) showed high cytotoxic activity against certain human
tumour cell lines.
Recently, research has been directed towards the area of memory inhibition,
whereby protein synthesis is required for brain memory retention. (-)-
Anisomycin [1] has been shown to interfere with long-term memory function
due to its ability to act as a protein synthesis inhibitor and is thought to have
the potential to selectively control or remove “fear or trauma”, memories13,14.
51.1.3. Stereochemistry and absolute configuration.
Whilst the elucidation of the general structure of (-)-anisomycin [1] was
comparatively trivial, exposition of the relative stereochemistry was not
entirely straightforward. Beereboom et al.6 conducted a study of anisomycin
[1] in 1965 by the use of chemical analysis in an attempt to unlock its
structure and stereochemistry. Titration of (-)-anisomycin [1] indicated the
presence of nitrogen as an amine with a pKa of 7.9, whilst infra red and
ultraviolet absorption revealed the existence of a hydroxyl group, an ester and
an aromatic portion. The UV spectrum suggested that the aromatic ring
system of anisomycin was analogous to that of p-anisyl alcohol, but oxidative
degradation of [1] to draconic or p-anisic acid with “Condy’s crystals” in
water and sodium hydroxide left no doubt as to the presence of the p-
methoxyphenyl group. Definition of the ester group was concluded via acid
and base hydrolysis reactions which gave only deacetylanisomycin [4] and
acetic acid as final products. With the external architecture of the molecule all
but identified and the molecular formula indicating the presence of a second
ring, the core of the compound came under scrutiny. Zinc dust steam
distillation confirmed the existence of a pyrrolic material, whilst bromine and
a platinum catalyst established the absence of any sp2 hybridised carbons,
thus confirming the pyrrolidine ring nucleus as opposed to a pyrrol or
pyrroline6.
A further series of reactions and chemical analysis was conducted on the
antibiotic [1] and Beerboom et al. finally reported the structure as 2-p-
methoxyphenylmethyl-3-acetoxy-4-hydroxypyrrolidine [2] (Fig 1.3),
whereby he stated, albeit incorrectly, that the substituent’s on the pyrrolidine
ring were trans in relation to the adjacent substituents6.
6Figure 1.3: Beerboom’s proposed structure for (-)-anisomycin6, illustrating
his all-trans configuration for the three asymmetric centres.
An x-ray crystallographic study by Schaefer et al.15 into a derivative of
anisomycin, N-acetylbromoanisomycin [3] (Fig 1.4), together with 1H NMR
analysis6 and a private communication from the Connecticut group in 1967
concluded that the p-methoxybenzyl appendage was in fact cis to the adjacent
acetate group15.
Figure 1.4: N-acetylbromoanisomycin15.
Wong et al. finally resolved any ambiguity and deduced the absolute
configuration in 1968 to be 2R,3S,4S, via chemical correlation studies with
the amino acid L-tyrosine16 and further verified this deduction with the
synthesis of (-)-deacetylanisomycin [4] and (+)-deacetylanisomycin [5] from
(+)-tartaric acid later that same year17. (Fig 1.5).
7Figure 1.5: Wong et al’s. absolute configuration of (-)-anisomycin together
with (-) and (+)-deacetylanisomycin16,17.
1.1.4. Biosynthesis.
Notwithstanding the erroneous assignment of the trans substituents on the
pyrrolidine ring, Dr Kenneth Butler from Pfizer’s Connecticut laboratories,
published a biosynthesis of anisomycin [1] in 1966. Whilst investigating both
the structure and extraction techniques of anisomycin [1] it became apparent
to Butler that the alkaloid could be derived from several amino acids, namely
tyrosine, phenylalanine and proline, and thus, these amino acids could be
used as precursors in a total synthesis.18
A series of a labelled amino acid and degradation studies concluded that
deacetylanisomycin [4] was converted to anisomycin [1] in the assimilation
phase of the fermentation process when the acetic acid concentrations had
peaked; it was clear however, that its antecedent did not accrue from proline
during the logarithmic phase of growth.
8Figure 1.6: Butler’s biosynthesis study results.18
Both tyrosine [6] and phenylalanine [7] were shown to be major precursors in
the formation of the antibiotic’s aromatic moiety together with C2 of the
pyrrolidine ring; however, the non-essential amino acid was shown to be
incorporated foremost, with phenylalanine [7] 40 times less efficient. (Fig
1.6)18
Attention now, was turned to anisomycin [1] and deacetylanisomycin [4]
isolated from the fermentation broth incorporating labelled acetate [8],
glycine [9] and methionine [10]. It was anticipated that by measuring the
radioactivity in the remnants of degradation, the remainder of the puzzle
could be realised.
Structured disintegration of deacetylanisomycin [4] with the 2-14C glycine
isotope [9] was instigated by exhaustive methylation to N-
methyldeacetylanisomycin methiodide [12] via refluxing potassium carbonate
and methyl iodide in acetone. Execution of the concluding element of the
Hofmann degradation18 was to fragment the pyrrolidine core with refluxing
9sodium hydroxide to give 1-(p-methoxyphenyl)-3,4-dihydroxy-5-
dimethylamino-1-pentene [13].18 Glycolic cleavage of the vicinal diol [13] to
p-methoxycinnamaldehyde [14] and dimethylaminoacetaldehyde [15] was
achieved by way of lead tetraacetate oxidation. With the glycine isotope
activity measured as an uneven split of 43.5% in aldehyde [14] and 56.5% in
the tertiary amine [15]; carbon 4 and 5 of the pyrrolidine ring had been
identified. (Scheme 1.1)
Further oxidation of [15] with potassium permanganate lead to N,N-
dimethylglycine [16] which was absorbed onto calcium oxide before
pyrolysis gave trimethylamine [21]. Radioactive analysis of the amine salt of
[21] reconfirmed the presence of 14carbon at C5 of the anisomycin core.18
Scheme 1.1: Butler’s biosynthesis degradation study18.
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The chemical analysis of [1] using a labelled methionine [10] and acetate [8]
isotopes was largely inconclusive due to solubility issues, fermentation acetic
acid concentration and the low boiling points of the degradation relics. Butler
reported that the methionine [10] presumably undertook its customary role as
a biological methylating agent and accounted for the aromatic methoxy
group; and acetate [8], probably as acetyl co-enzyme A [11] was responsible
for the acetyl group, considered to be the final step in the biosynthesis. The
origin of C3 was not thought to come from the tyrosine or phenylalanine’s
carboxylic acid group due to decarboxylation in the early stages of
fermentation, thus the source of C3 was undetermined together with that of
the nitrogen18.
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1.1.5. Previous syntheses.
Anisomycin’s biological profile has attracted considerable interest from the
scientific community over the last half century and many organic chemists
have been tempted into resolving an efficient synthetic route to what is a
comparatively simple molecular structure with a chirally challenging
configuration. (-)-Anisomycin [1] has been successfully synthesized through
21 different routes, with chemists generally employing the readily available
chiral pool of amino acids and carbohydrates. However, because of the
necessity of continued protecting group chemistry and the inherent difficulty
in separating undesirable stereoisomers, the efficiency of many of these
routes has been compromised resulting in syntheses frequently in excess of 20
steps.
The first successful total synthesis of anisomycin [1], albeit racemic, was
published in 1969 by Oida et al19. whereby the strategy for the synthesis drew
upon their previous work on 3,4-trans-disubstituted pyrrolidines20 and the
biosynthesis of Butler three years earlier18.
Scheme 1.2
12
The Sanko group reasoned their pertrifluoroacetic acid oxidation21 to form an
epoxide across the double bond of a pyrroline would serve as a target
intermediate [26] for the synthesis, with the proteinogenic amino acid
tyrosine [22] chosen as the suitable starting material19.
Tyrosine [22] was converted to the methoxybenzyl-propanoate [23] in 4 steps
by way of McKinney’s cyanoethylation procedure22 and successive treatment
with hydrogen chloride in ethanol. Amine protection with acetic anhydride in
methanol was followed by O-methylation with dimethyl sulfate in acetone in
the presence of potassium carbonate. The 1,6-diester [23] lent itself
favourably to undergo intramolecular cyclisation to form the pyrrolidine ring
via the Dieckmann cyclisation to give β­keto ester [24] (scheme 1.2).
Scheme 1.3
The keto functionality introduced at C3 of [24] by the cyclisation enabled the
molecule to be manipulated to the key intermediate [26] relatively efficiently.
Removal of the adjacent carboxylate with HCl in acetic acid followed by
Stoichometric addition of tosyl hydrazine furnished tosyl hydrazide [25].
Potassium hydroxide in the protic solvent diethylene glycol instigated the
13
Bamford-Stevens reaction necessary to install the double bond at carbon 3
and 4 of the ring with concomitant amine deprotection (Scheme 1.3).
Scheme 1.4
Alternate amine protection was sought with benzoxycarbonyl chloride before
treatment of the double bond with pertrifluoroacetic acid to form the desired
α­epoxide [27]. Addition of trifluoroacetic acid with sodium trifluoroacetate
promoted solvolysis, whereby interaction with the acid fragmented the
strained three-membered ring to yield the required pyrrolidine skeleton [28]
containing the elusive yet crucial chiral centres on carbons 2, 3 and 4 and a
redundant inseparable stereoisomer19. (Scheme 1.4)
Acetylation of alcohol [28] with acetic anhydride in pyridine completed the
architecture of C3, whilst the unstable trifluoroacetyl group was removed
with dilute HCl and water to concluded C4. The mixture of stereoisomeric
monoacetates was subjected to hydrogenation over palladium and charcoal to
remove the benzyloxycarbonyl protection and reveal anisomycin together
with the analogous stereoisomer. Separation of the monoacetates by
14
recrystalisation in ethyl acetate and hexane (5:1) completed Oida’s 13 step
route and the first total synthesis of anisomycin19.
Oida et al’s. target intermediate, (R)-2-(p-methoxyphenyl)methyl-2,5-
dihydropyrrole [26] was also the objective for Jegham et al’s. formal
synthesis of (-)-anisomycin [1] from D-tyrosine, together with (+)-
anisomycin [1a] from L-tyrosine [22].  Formation  of  an  α,β­unsaturated
methyl ester prior to cyclisation was the key step in the synthesis23.
Scheme 1.5
Reduction to the alcohol of the ortho-methyl, Boc protected methyl ester
fashioned from D-tyrosine, was achieved with sodium borohydride and
lithium chloride. This was followed by a Swern oxidation30 to give aldehyde
[29]. The chain elongation and olefination was made possible by the Horner-
Wadsworth-Emmons reaction with the anion derived from bis-(2,2,2-
15
trifluoroethyl)-(methoxycarbonylmethyl)-phosphonate. The use of the
trifluoroethyl ligands on the phosphonate are thought to enhance the rate of
elimination when the oxaphosphetane [29c] intermediate is formed, thus
ensuring the all important cis configuration is achieved to enable cyclisation.
This represents the Still-Gennari123 modification of this reaction and formed
the (Z)­γ­amino­α,β­unsaturated methyl ester [30]. (Scheme 1.5)
Conversion of the ester group to the alcohol [31] and then onto the mesylate
[32] for Sn2 leaving functionality, allowed sodium hydride persuasive
intramolecular cyclisation to take place and form pyrroline [33] without
racemisation of the chiral centre. Trivial removal of the Boc protection
completed this formal synthesis to [26] in an overall yield of 62%. (Scheme
1.6)
Scheme 1.6
Acknowledgement was attributed to Hall et al24. and Meyers et al25. for the
conversion of [26] to [1] and these two routes will be discussed further in this
review.
Shono et al’s. sparse report in 1987 on the formal synthesis of (-)-anisomycin
[1]26 also utilised D-tyrosine as a starting material and employed an
16
intramolecular cyclisation to form the core of the compound, but the key
reaction was the electro-generated (methoxycarbonyl)-methyl anion for
addition to an aldehyde to form the cyclisation halosynthon27.
DIBAL reduction of the methyl ester on the methoxycarbonyl protected D-
tyrosine gave access to aldehyde [34]. Electrochemical reduction of the
chloro-acetates formed the DMM anion and on addition to [34] generated an
α­geminal  chloride  on  the  methyl  pentanoate [35] prior to cyclisation.
Hydrolysis with acid followed by treatment with sodium bicarbonate induced
formation of the γ­lactam [36] in a 65% yield. A further 4 step manipulation
of the γ­lactam gave the trans diol of (-)-deacetylanisomycin [4]26. (Scheme
1.7)
Scheme 1.7
An efficient synthesis of enantiomerically pure (-)-deacetylanisomycin [4]
from D-tyrosine, which also constitutes a formal synthesis of (-)-anisomycin
[1] was reported by Chandrasekhar et al. in 200228. Several classic named
reactions were employed in this synthesis, but possibly the key reaction was
the modified Sharpless asymmetric dihydroxylation29 to install the chiral diol.
17
Scheme 1.8
The Boc protected alcohol [37] residue of D-tyrosine was subjected to a
Swern oxidation30 and followed up without purification by a Wittig reaction
with  (ethylcarbonylmethylene)­triphenylphosphorane  to  form  the  γ­amino­
trans­α,β­unsaturated ethyl ester [38] in a 73% yield.
The trans geometry of the olefin enabled the creation of the (2R, 3S, 4R)
configured chiral diol [39] using the Sharpless asymmetric dihydroxylation
with AD­mix­α. Following osmylation, the two hydroxyl groups were bound
by acetonation to allow unimpeded manipulation of the ethyl ester [40] to the
required period 4 halogen [41] over two steps. The protecting groups were
removed via TFA induced acidolysis and the resultant amine was tempted to
cyclise with triethylamine to give (-)-deacetylanisomycin [4] in a 70% yield28.
(Scheme 1.8)
Hulme et al. considered an aldol based approach to (-)-anisomycin [1]31 and
reported a successful 13 step synthesis of (-)-anisomycin [1] in 2002 from D-
tyrosine [22] and a glycolate derivative of Evans’ oxazolidinone [45]32.
Drawing  upon  experience  gained  on  their  previous  synthesis  of  the  α­
glucosidase inhibitor 1,4-dideoxy-1,4-imino-D-arabinitol, the Edinburgh
18
group employed a similar strategy to construct the pyrrolidine cyclisation
precursor [47].
Scheme 1.9
The Swern oxidised aldehyde [42] was converted from D-tyrosine in 7 steps
to form one half of the aldol system, with the second element fashioned from
benzyloxyacetyl chloride and (R)-4-benzyloxazolidin-2-one to assemble the
Evans type oxazolidinone [45]. (Scheme 1.9)
Scheme 2.0
Formation of the (Z)-boron enolate [45a] (Scheme 2.0) gave rise to the syn-
aldol adduct [46] before metal hydride reductive cleavage of the benzyl
19
oxazolidinone moiety revealed the desired 1,3-diol [47]. Selective primary
alcohol tosylation with tosyl chloride and DMAP, encourage spontaneous
ring closure to give the pyrrolidinium tosylate salt, which upon treatment with
1% HCl on Dowex ion exchange resin was converted to the chloride salt [48].
A further 3 step manipulation of gave (-)-anisomycin [1] as its hydrochloride
salt [49] in a 35% overall yield31. (Scheme 2.1)
Scheme 2.1
D-Tyrosine was again utilised in a recent novel approach to (-)-anisomycin
[1] by Ham et al.33 who used a palladium catalysed stereoselective
intramolecular oxazine ring formation as the penultimate target before
successfully converting it to [1].
Familiar formation of the D-tyrosine amino protected methyl ester derivative
was also employed by Ham et al. as a starting point in the most recent
synthesis of [1]. However, in a deviation to the previous syntheses whereby
aldehyde mediated chain extension was used,23,26,28,31 conversion of the
methyl ester to the Weinreb amide [50] enabled tin radical chemistry to
furnish  an  α,β­unsaturated  ketone [51]. Stereoselective reduction of the
ketone was necessary to generate the anti-periplainer relationship between the
amine and the alcohol [52] to facilitate the p-nitrobenzoic acid catalysed
Mitsunobu type trans oxazoline [53] formation. (Scheme 2.2)
20
Scheme 2.2
Acid catalysed hydrolysis followed by moderate pH elevation secured the
syn-amino alcohol, which was subsequently silyl protected [54] before
palladium mediated ring formation at 0°C ensured the kinetically formed syn-
oxazine [55].
Ham et al.34 demonstrated that temperature was critical in obtaining the
correct diastereoselectivity. It was postulated that the molecule would adopt
the chair-like transition state with the bulky silyl group sitting in an equatorial
orientation  to minimise  the  conformational  energy. Whilst  the  initial  π­allyl
palladium complex, in the axial configuration [54a] at 0°C, does suffer slight
synclinal alignment repulsion due to the 60° torsion angle with the vicinal
silyl group; it does not suffer the destabilising steric inhibitions that it
undoubtedly would if it were equatorial [54b].
21
Scheme 2.3
Upon formation of the secondary intermediate [54c] and onto cyclic
completion, the syn product [55] is undoubtedly preferred over the sterically
impeded transitional state of [54b] even allowing for the 1,3-psuedioaxial
interaction of the pendant vinyl group with the aromatic moiety [54e].
However, an increase in reaction temperature enables the higher energy
barrier for the formation of transition state [54b] to be overcome and on
22
completion of ring formation and loss of the palladium the steric issues for
the thermodynamic product [56] vanish.34 (Scheme 2.3)
Hydroxyl group protection exchange via acetylation [57] enabled ozonolysis
of the pendant vinyl group prior to the second employment of the group 10
metal, this time as Pearlman’s catalyst. Hydrogenation of the oxazine and
aldehyde groups enabled spontaneous cyclisation of the aminoaldehyde
intermediate to reveal (-)-anisomycin as a single stereoisomer in an overall
yield of 27%.33 (Scheme 2.4)
Scheme 2.4
Verheyden’s 1978 selective chiral synthesis of anisomycin35 took advantage
of the carbohydrate chiral pool instead of the amino acids. The Syntex
Research group considered that the asymmetric carbons at the centre of [1]
were also mimicked in the core of the aldohexose, D-glucose. The formation
of  the  amino­β­L­talofuranose  key  intermediate [61] enabled the resultant
bicyclic furo-pyrrolidine to contain the necessary regio and stereo-chemical
functionalities to complete an efficient synthesis.
23
Scheme 2.5
The  diacetonide  protected  α­D-glucofuranose [58] allowed for tosyl
conversion of the solitary alcohol together with its stereochemical volte-face,
before selective hydrolysis of the 5,6-acetonide revealed the 1,2-diol [59] in
an 88% yield. Selective benzoate protection of the primary alcohol permitted
formation of the mesyl ester on the remaining hydroxyl group [60] and this in
turn allowed for translation to the oxirane [61]. Reaction of the epoxide with
sodium azide initiated attack at the least hindered primary position thus
installing the azido group and the resultant alcohol. Reduction to the amine
via  palladium  catalysed  hydrogenation  completed  the  key  amino­β­L­
talofuranose intermediate [62]. (Scheme 2.5)
Cyclisation to form the pyrrolidine ring was instigated by refluxing [62] with
sodium acetate in ethanol before installation of the carbamate protection.
Sodium hydroxyl assisted benzylation covered the alcohol at C3 of the
pnictogen heterocycle prior to treatment with tri trifluoroacetic acid to cleave
the 1,2-acetonide to form an anomeric mixture of diol [63] in 92%. Key
oxidative fragmentation of the furan ring not only revealed the skeleton of the
target alkaloid complete with the correct stereochemistry but also provided
24
the aldehyde [64] functionality to facilitate the final aryl architecture.
Successful attachment of the arene [65] was completed by the p-magnesium
bromide Grignard of anisole in THF followed with a further 4 steps to
conclude the natural compound [1] in an overall yield of 8%.35 (Scheme 2.6)
Scheme 2.6
Buchanan et al. also exploited the carbohydrate pool and reported the use of
the monosaccharide, D-ribose for an enantiospecific synthesis of (-)-
anisomycin. The cyano-dioxolane cyclisation precursor [68] was the target
intermediate following addition of the aryl group.36,37
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Scheme 2.7
Grignard attachment to install the anisole group effected collapse of the
furanose ring and gave rise to the triol [67]. Further manipulation through to
the hemiacetal and onto the oxime finally resulted in the desired nitrile key
intermediate [68]. Lithium aluminium hydride reduction enabled forced
mesyl displacement and creation of the pyrrolidine ring with an all cis
configuration [69] before progression to the natural product [1] in an overall
yield of 10%.36,37 (Scheme 2.7)
An early exponent of the synthesis of (-)-anisomycin [1] was von Felner et al.
in  1970  whereby  the  formation  of  a  γ­thiolactam  key  intermediate  from
diethyl-L-tartrate [70] enabled addition of the methoxy-aryl moiety via
Eschenmoser’s sulfide contraction.38,39,40
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Scheme 2.8
Following an unsuccessful attempt to attach the methoxy arene moiety to an
imino-ester derivative of [71] von Felner et al. modified their approach by
conversion of lactam [71] to the γ­thiolactam [72]. (Scheme 2.8)
Scheme 2.9
The addition of [72] with tert-butyl-2-bromo-2-(4-methoxyphenyl)-acetate
[73] together with phosphorus pentasulfide in benzene translated to the sulfur
bridged aryl-pyrroline [74]. Eschenmoser’s sulfide contraction initialised with
trimethyl phosphate, dimethyl sulfoxide and catalytic potassium tert-butoxide
induced formation of the spiro-thiirane intermediate [74a] before phosphate
abstraction of the sulfur collapsed the 3 membered ring to give the
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benzylidene [75]. (Scheme 2.9) A further 3 and 8 step manipulation
proceeded to give (-)-deacetyl anisomycin [4] and (-)-anisomycin [1]
respectively.38,39,40
Although mentioned earlier in this report for clarifying the absolute
stereochemistry of [1],16 Wong et al’s. configurational studies concluded in
reporting the synthesis of (-)-anisomycin [1] and (+)-anisomycin [1a]
together with (-)-deacetyl anisomycin [4] and (+)-deacetyl anisomycin [5]
from both L-tartaric acid [76] and α­anisyl pyrrole [81].17,41
Scheme 3.0
The addition of the aromatic moiety to N-Benzyl tartrimide [77], fashioned
from L-tartaric acid [76], was achieved by reacting an in-situ formed anisyl-
magnesium chloride Grignard reagent with tartrimide [77] in THF. However,
Wong et al. discovered that if lithium aluminium hydride was added to the
reaction mixture before the excess Grignard was quenched, three products
were formed, [78], [79] and the desired [80] in 2%, 12% and 3% yields
respectively.17,41 (Scheme 3.0)
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Debenzylation of the conformationally correct trans diol [80] with Pd/C in
acidified ethanol gave the hydrochloride salt of (-)-deacetyl anisomycin [4]
with liberation to its free base via sodium hydroxide.41
Wong et al’s. second approach to anisomycin was to use the target molecule’s
aromatic portion combined with the 5-membered core as the starting material.
A Clemmenson reduction42  of  α­anisyl  pyrrole [81] with a zinc/mercury
chloride amalgam furnished the vital sp2 hybridised function at carbons 2 and
3 [82]. Treatment of the newly formed alkene [82] with acetic anhydride
followed by peracetic acid oxidation gave way to epoxides [83] and [84].41
(Scheme 3.1)
Scheme 3.1
Conversion of epoxide [84] to a racemic mixture of deacetyl anisomycin was
concluded by refluxing in glacial acetic acid followed by basic hydrolysis.41
N-Protection of (+)-deacetyl anisomycin [5] with benzyl bromide gave the
enantiomorph of [80] which in turn was treated with acetic anhydride to form
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the N-benzyl-anisomycin [86]. Wong et al. suggested that the selective
acetylation of the C2 hydroxy group was achieved due to the pyrrolidine ring
adopting its most stable conformation [85a] with the lone pair of electrons on
the nitrogen in a cis configuration with the aromatic group and the C2
hydroxyl group.17,41 (Scheme 3.2)
Scheme 3.2
Debenzylation of the nitrogen with 5% Pd/C with HCl gave the hydrochloride
salt of (+)-deacetyl anisomycin before sodium hydroxide treatment released
the monobasic pyrrolidine [5].
Wong et al. affirmed that the conversion of [80] to [1] was achieved using the
same method which formed (+)-anisomycin [1a], however the experimental
data is not reported.41
Hall et al’s. synthesis of (±)-anisomycin also employed Wong’s 2-(p-
methoxy-benzyl)-pyrrole [81] route by uniting pyrrole-2-carboxaldehyde [87]
and anisyllithium in a tandem alkylation-reduction procedure. Whilst
utilisation of this technique was fundamental at the onset of the synthesis, the
regioselective and stereospecific opening of the syn-epoxide was arguably the
significant reaction step. The lithium-benzyl-alkoxide intermediate [88] was
reduced to  the α­anisyl pyrrole [81] via sequential treatment with ammonia,
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lithium and ammonium chloride in a 98% yield with no adverse reduction of
the pyrrole in accordance with O’Brien and Smith.43,44, (Scheme 3.3)
Scheme 3.3
With the molecular framework fabricated efficiently in the one-pot tandem
reaction, partial reduction of the pyrrole [81] to 2-(p-methoxybenzyl)-3-
pyrroline [82] was concluded by the McElvain procedure45 rather than the
Clemmenson reduction42 in a modest 67%. Hall’s strategy relied on forming
an epoxide across the double bond at the head of the emergent molecule to
enable the vicinal appendages to be set by regio and stereospecific
fragmentation. Reaction of the olefin with NIS in perchloric acid and THF
formed the short-lived iodiranium cation [89] before collapsing to form
iodohydrin [90] as a single stereoisomer. Hall et al. suggested that the steric
influence of the bulky methoxyaryl group focused regioselective attack to the
rear of the C4 position of the strained iodiranium.24 (Scheme 3.4)
Scheme 3.4
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Potassium hydroxide (10% in ethanol) converted the halohydrin to the desired
epoxide before removal of the carbamate protecting group. It was firmly
advocated that reduction to the free amine was necessary to ensure success of
the second regio and stereospecific ring fragmentation to form (-)-deacetyl
anisomycin [4]. Refluxing trifluoroacetic acid with sodium trifluoroacetate
induced cleavage of the syn epoxide before reintroduction of the amine
protection.24 (Scheme 3.5)
Scheme 3.5
Selective  trichloroethyl  carbamate  protection  of  the  4α­hydroxy  group  in
DCM with pyridine enabled acetylation of the remaining hydroxyl group with
acetic anhydride. Sequential hydroxyl and amine deprotection with zinc in
THF and acetic acid followed by conventional catalytic hydrogenation
finalised the synthesis in an 8% overall yield.24
An efficient 11 step synthesis of (-)-anisomycin [1] exploiting both the
Sharpless asymmetric epoxidation and asymmetric dihydroxylation reactions
was utilised by Lin et al. in 1995 and culminated in an elegant intramolecular
cyclisation final step to complete the alkaloid in a 12% overall yield.46
Conversion of divinylcarbinol [92] to the epoxide via the titanium IV
mediated Sharpless asymmetric epoxidation reaction followed by
trimethylsilyl protection of the alcohol gave the oxirane [94]. Successful
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bromomagnisium Grignard coupling of the anisyl group to the unhindered
position of the cyclic ether not only installed the aromatic entity but also
allowed the oxirane residue to provided the functionality to establish the
future amine presence.46 (Scheme 3.6)
Scheme 3.6
Asymmetric dihydroxylation on olefin [96] with catalytic osmium tetroxide
and chiral ligand DHQ-CLB enabled formation of the 2,3-erythro-triol [97].46
(Scheme 3.7)
Scheme 3.7
Sequential manipulation of the three hydroxyl groups over 5 steps resulted in
the bromo-azide [98] penultimate compound. Hydrogenation of the
bromohydrin [98] with catalytic palladium on charcoal followed by a sodium
acetate in methanol reflux revealed (-)-anisomycin [1] in a 58% yield.46
(Scheme 3.8)
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Scheme 3.8
Kang et al. demonstrated that aziridines, like their chalcogenic analogues,
could also be used in conjunction with an identical Grignard to introduce the
aromatic substituent to the emerging alkaloid.47
Scheme 3.9
Treatment of the acetonide aziridines [100] and [101], fashioned from the
aminoiodotriol [99], with anisylmagnesium bromide in the presence of a
cuprous bromide dimethyl sulfide complex followed by acid hydrolysis of the
acetonide and Boc protection of the amine gave the amino-triol [102] as
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Kang’s key intermediate. Cyclisation to (-)-deacetyl anisomycin [4] under
PPTS modified Mitsunobu conditions followed by successive silylation and
acetylation enabled simple acid hydrolysis to gain the target alkaloid [1].47
(Scheme 3.9)
In a recent attempt, Reissig’s devised an ambitious synthesis involving a
diacetone-fructose substituted allene coupling with an N-protected imine
precursor before subjecting the resultant molecule to a base catalysed
intramolecular cyclisation.48
Reissig et al. envisages that the chiral entity of the 1,2:4,5-di-O-
isopropylidenefructose would ensure high diastereoselectivity in the lithiated
allene/imine reaction. It was considered that with its sterically hindered rear
side, the allene would attack the Si face of the imine to provide the desired
(R)-configuration at the newly formed stereocentre; however, a modest 2:1
ratio in favour of the desired isomer was not improved upon.48 (Scheme 4.0)
Scheme 4.0
The N-Boc-protected allenylamines [105] were cyclised under strong basic
potassium tertiary butoxide in DMSO conditions to afford a mixture of the
two diastereoisomers of pyrroline [106] in a 65% yield with no change in the
ratio. After separation pyrroline [106] was taken forward in a further 6 steps
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to successfully complete the synthesis as the hydrochloride salt of [1] in an
overall yield of 8%.48 (Scheme 4.1)
Scheme 4.1
Kibayashi’s highly selective synthesis of (-)-anisomycin [1] starting from
diethyl-L-tartrate [107], attempted an unsuccessful Grignard addition of the
aryl moiety to the L-threitol derived aldehyde [108]. However, catalytic
deprotection of the terminal benzyl of [108] induced cyclisation to the lactol
[109] which in turn, did succumb to Grignard addition forming the
diastereoisomers [110a] and [110b] in a 79:21 ratio in favour of the undesired
xylo-isomer [110a].49 (Scheme 4.2)
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Scheme 4.2
Inversion of the 4-hydroxyl group was required to enable formation of the
azide key intermediate [113] crucial to obtain the necessary 2R,3S,4S
configuration in the final product.
Scheme 4.3
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Selective benzylation of the diastereoisomeric mixture with successive Swern
oxidation furnished ketone [111] and treatment with zinc borohydride enabled
diastereofacial  control  of  the  α,β­alkoxy  carbonyl  chelation  for  the  hydride
reduction.49,50 (Scheme 4.3) Spontaneous cyclisation of [113] via
intramolecular mesyl displacement following catalytic hydrogenation caused
configuratory inversion to give dimethoxymethyl protected deacetyl
anisomycin with the correct stereochemistry. A further six steps including
selective benzyl and silyl protection of the amine and 4-hydroxy group
respectively allowed unimpeded acetylation followed by systematic
deprotection to give the desired target [1] in a 2% yield over 18 steps.49
Baer et al. like their predecessors, Verheyden and Buchanan vida supra, also
elected to utilize the carbohydrate pool as a chiral template. It was considered
that the trans glycol motif of D-galactose would serve well to form the
awkward stereochemical C3 and C4 embodied in the final product and the C5
and C6 pendant would elaborate to the benzylic substituent.51
D-galactose was converted to the glycol protected β-D-galactofuranoside
[114] over five multigram standard reactions before periodate oxidation gave
the dibenzyloxy aldehyde [115]. Treatment with in situ generated (4-
methoxyphenyl)-magnesium bromide attached the aryl group forming a
mixture of epirmeric alcohols [116].51 (Scheme 4.4)
Scheme 4.4
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Ionic deoxygenation using triethylsilane with trifluororacetic acid converted
the benzylic hydroxyl groups to the methylene and gave ethyl-2,3-di-O-
benzyl-5-C­(4­methoxyphenyl)­α­L­arabinofuranoside,  whilst  an  acetic  acid
reflux afforded the alcohol [117] as an anomeric mixture.51
Scheme 4.5
Formation of the oximes [118a] and [118b] as an E,Z mixture was achieved
by fragmentation of the furanoside with hydroxylamine hydrochloride in
pyridine and ethanol. Treatment of the aldoximes with methanesulfonyl
chloride induced dehydration with simultaneous O-mesylation to give the
nitrile mesylate cyclisation precursor [119]. Whilst employing Buchanan et
al’s precedent to their analogous reductive cyclisation reaction to achieve
similar results, Baer’s preference was to use diborane in THF to ensure a
greater yield of the desired pyrrolidine [120]. Debenzylation via catalytic
hydrogenation in the presence of formic acid completed the formal synthesis
in an 18% overall yield.51 (Scheme 4.5)
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Yoda et al. developed an economic route to (-)-deacetyl anisomycin [4], and
like Shono et al. previously,  formed  a  substituted  γ­lactam  as  the  key
intermediate via intramolecular cyclisation.26 Amination of commercially
available 2,3,5-tri-O-benzyl-β-L-arabinofuranose with benzylamine replaced
the solitary hydroxyl to form the furanosylamine [121].
Scheme 4.6
Grignard fragmentation of the ring via approach to the least hindered side
ensured a high yield of the single stereoisomer [122]. Treatment with
pyridinium chlorochromate enabled ring closure to form the desired γ­lactam
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[123] with the correct stereogenic centres, whilst catalytic debenzylation and
hydride reduction of the carbonyl concluded the global deprotection and the
formal synthesis.52 (Scheme 4.6)
Petrini et al. considered a different approach into uniting both rings of the
alkaloid. It was felt that the nitrogen within the pyrrolidine ring could be
integrated  as  part  of  a  nitrone  functionality  and  that  the  carbon  α  to  the
nitrogen would be electrophilic enough to undergo attack from a suitable
Grignard reagent. N-benzyl tartrimide [77] prepared from L-tartaric acid [76],
parallel to the Wong et al.17 procedure, underwent methoxymethyl protection
of the trans diol and debenzylation to give the secondary amine [124].
Scheme 4.7
Translation to the nitrone [125] via hydrogen peroxide oxidation in the
presence of catalytic selenium dioxide enabled addition of the aryl group. The
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reaction of (p-methoxybenzyl)-magnesium chloride in THF produced a
mixture of diastereomers [126a] and [126b] in a 2:3 ratio in favour of the
undesired isomer [126b]. However, the addition of 1 equivalent of
magnesium bromide diethyl etherate in DCM allowed for magnesium/oxygen
coordination, thus altering the diastereoselectivity to give predominantly the
desired cis product [126a]. Catalytic hydrogenation with Raney nickel and
subsequent acid hydrolysis gave (-)-deacetyl anisomycin [4] in a 12% overall
yield.53 (Scheme 4.7)
In 2000, Larchevêque et al. reported a formal synthesis of (-)-anisomycin
based on a stereoselective reductive alkylation of a polyhydoxylnitrile
derivative.54 Previous work by the Paris group on 2,3-dialkylnitriles provided
sound evidence that they were able to control the reaction to give the all syn-
protected aminodiol in high enantiomeric purity.55
Scheme 4.8
Formation of the protected trihydroxynitrile [127] target intermediate was
achieved from both L-tartaric acid [76] and L-threonic acid over five steps via
two different routes. Nucleophilic attack of the cyano group with p-anisyl
magnesium chloride formed the metalloimine intermediate before yielding in
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situ to the primary imine. Addition of benzylamine allowed for trans-
imination of the unsubstituted imine before reduction with sodium
borohydride gave a mixture of syn and anti diastereomeric N-benzylamines
[128a] and [128b] in an 81:19 ratio in favour of the desired threo product.54
(Scheme 4.8)
Manipulation of the syn protected amine [128a] to the mesylate from the
primary alcohol [129] enable acidic cleavage of the acetonide before base
assisted ring closure via the familiar intramolecular Sn2 displacement
reaction23,28,31,49 gave N-benzyl deacetyl anisomycin [129], whilst standard
debenzylation completed the ten step synthesis.54 (Scheme 4.9)
Scheme 4.9
Merino et al. like Petrini,53 also employed nitrone functionality in order to
attach the anisyl group; however, stereoselective nucleophilic addition to an
acyclic α­alkoxy nitrone56,57 instead of the nitrone being incorporated within
the pyrrolidine would pave the way to (-)-deacetyl anisomycin [4]. Nitrone
[133] was prepared by treatment of the protected D-threitol aldehyde
derivative [132] with N-benzylhydroxylamine and magnesium sulfate. The
addition of the p-methoxybenzyl Grignard yielded almost exclusively the syn
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adduct [134] thus setting the final chiral centre. Reduction of the
hydroxylamine [134] with a zinc/copper(II)acetate couple allowed
debenzylation to Larchevêque et al’s cyclisation precursor [129]. In a slight
deviation to Larchevêque’s final procedures to produce (-)-deacetyl
anisomycin [4], an overall yield of 28% concluded the synthesis.57 (Scheme
5.0)
Scheme 5.0
Jäger’s approach to (-)-deacetyl anisomycin [4]58 in 1996 developed an L-
threose imine key intermediate starting from monobenzylated L-threitol [136]
via 1,2-diol protection with acetone and p-toluene sulfonic acid59 followed by
Sarett oxidation to form the aldehyde [137]. Condensation of the aldehyde
with benzylamine gave the imine [138] necessary for the aryl coupling
reaction. Treatment of the imine [138] with the p-methoxymethylbenzene
Grignard produced the familiar analogous skeletal backbone31,47,54,57 of the
cyclisation precursor [139]; and modified Mitsunobu conditions finalised the
ring. Removal of the N-benzyl protection afforded the hydrobromide salt of (-
)-deacetyl anisomycin [4] in 34% yield over 7 steps.58 (Scheme 5.1)
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Scheme 5.1
An interesting, if not tortuous route to Kibayashi’s key intermediate [110b]49
was developed by Akita et al. and included a stereoselective nucleophilic
substitution coupled with a 1,2 aryl migration.
Scheme 5.2
The (E)-unsaturated methyl ester [142] from D-mannitol was converted to the
(R)-epoxide [143] over seven steps. Introduction of the anisole group with
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boron trifluoride diethyl etherate at the expense of the epoxide furnished
alcohol [144] which was then converted to the bromide [145]. (Scheme 5.2)
To induce aryl migration, the bromo-methyl ester [145] was treated with
silver nitrate in nitromethane with 4Ǻ molecular sieves. Akita suggested that
a cationic spiro-cyclopropane intermediate species would form, whereby
nucleophilic fragmentation via the ambident anion would complete the
aromatic shift and establish the nitrate functionality with inversion at the C4
position [146].60,61 (Scheme 5.3)
Scheme 5.3
Conversion of the nitrate [146] to the (4S)-alcohol [147] allowed for catalytic
osmium tetroxide to bind to the least sterically hindered β-side of the trans
olefin to undergo dihydroxylation before treatment with N-morpholine-N-
oxide to produce the 3,4-anti­γ­lactone [148]. Protection of the diol was
concluded with chloromethyl methyl ether and Hünig’s base before DIBAL
reduction gave Kibayashi’s intermediate [110b].60,61 (Scheme 5.4)
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Scheme 5.4
Takano et al. devised an enantioconvergent route to Oida’s 3-pyrroline
intermediate [26]20 for their formal synthesis, utilising both the (S)- [149] and
(R)- [150] enantiomers of epichlorohydrin. Although both could be fashioned
from D-mannitol via McClure’s synthesis,63 commercially available supplies
were employed as the starting materials. Transformation of both (S)- and (R)-
epichlorohydrin to the single key epoxide target [151] together with
installation of the anisole moiety was achieved in two and seven steps
respectively.
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Scheme 5.5
The oxirane [151] was converted to the acetylene [152] by reaction with
lithium acetylide ethylenediamine and subsequently reduced to the alkene
with Lindlar’s catalyst. The secondary alcohol was subjected to Mitsunobu
conditions to give the phthalimide [153] with inversion of the
stereochemistry, before reduction to the primary amine.62 (Scheme 5.5)
Scheme 5.6
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The selection of the benzoyl protection for amine was essential in that the
amide created would be intrinsic in the formation of the cyclisation product.
Treatment of the amide [153] with three equivalence of iodine in acetonitrile
proceeded to form the iodiranium 3-membered ring [154a] across the alkene,
which in turn collapsed following formation of the dihydro-oxazinium species
[154b]. The intermediate evolved further into the bicyclic-oxazolidinium
[154d] with the water present in the reaction, before finally resolving to a 2:1
mixture of epimers of the pyrrolidine benzoate [155]. (Scheme 5.6) The
amine [155] was once again protected but to the benzyl carbamate which
allowed for benzoyl conversion to the xanthate [156] via the hydroxyl. High
temperature reflux in ortho-dichlorobenzene ejected the xanthate and
installed the double bond and base hydrolysis completed the synthesis.62
(Scheme 5.7)
Scheme 5.7
Takahata et al. also developed an enantioconvergent strategy from a racemic
starting material to deliver Oida’s 3-pyrroline intermediate [26]20 for (-)-
anisomycin [1]; however in addition to this, the synthetic route also diverged
at a common key intermediate to complete the synthesis of (-)-detoxinine
[164]. N-(tert-butoxycarbonyl)-3-hydroxy-4-pentenylamine [159] was readily
obtained using a Sharpless kinetic resolution protocol to give the optically
pure (R) isomer in 36% yield from racemic [158] and >90% ee.
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Stereoselective amidomercuration followed by replacement of the acetate
with bromide [160] allowed for silyl protection of the hydroxyl group and
subsequent oxidation to give the primary alcohol [163]. The same Sharpless
asymmetric oxidation using the opposite chiral tartrate diester formed the
(3S,4R)-epoxy alcohol which in turn surrendered to the cis-1,3-pyrrolidine-
diol [161] via intramolecular amidation in 33% yield and >92% ee. A shorter
sequence of converting the diol [161] to the primary alcohol [162] used the
same silyl protection procedure, before selective monodesilylation with acetic
acid completed the convergence.64 (Scheme 5.8)
Scheme 5.8
The alcohol [163] underwent Swern oxidation treatment to form the aldehyde
[165] and it is at this key intermediate where the synthetic routes separate to
the different biologically active compounds. In situ formed 4-anisyllithium
afforded the coupled product which was then exposed to strong acid
conditions causing simultaneous desilylation, benzylic hydroxyl reduction
and butoxycarbonyl elimination. With the two functional groups exposed,
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amine protection was re-instigated in the form of a carboxybenzyl group
followed by conversion of the alcohol to the xanthate [167], identical to
Takano’s [156] but for the regiochemistry. Pyrolysis under reduced pressure
provoked Chugaev’s 6 membered cyclic transition state terminating in the syn
elimination and the new alkene. Completion of the formal synthesis was
accomplished with removal of the amine protection by sodium in aqueous
ammonia.64 (Scheme 5.9)
Scheme 5.9
Somfai utilised a microwave-assisted rearrangement of a vinylaziridine
derivative in a recent formal synthesis of (-)-anisomycin [1], again reaching
the 3-pyrroline [26].
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Scheme 6.0
A modified Brown allylation65 on p-methoxyphenyl acetaldehyde [168] with
allyl chloride allowed for boron assisted coupling with re face attack65 to give
the chlorohydrin [169]. Treatment with aqueous ammonia in methanol
formed the amino alcohol [171] via the vinyloxirane [170] in 52% yield over
2 steps and >95% ee.66 (Scheme 6.0)
Tosylation and ring closure of the amino alcohol [171] with potassium
hydroxide and 5 equivalence of tosyl chloride gave the cis-vinyl-aziridine
[172] which when treated with lithium iodide under microwave irradiation
rearranged to the N-tosyl pyrroline in an impressive 92% yield. Simple amine
deprotection completed the route in a 37% overall yield.66 (Scheme 6.1)
Scheme 6.1
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Initially starting with (S)-malic acid [173], Huang et al. reported in two
publications over 6 years the construction of Oida’s aryl methoxy dihydro-
1H-pyrrole [26]20 featuring a highly regio and stereoselective reductive
alkylation to attach the anisole group. Huang’s assembly of the N-benzyl
malamide [174] was analogous to that of both Wong and Petrini vida supra,
as well as the Grignard reagent chosen to attack the ketone. Reaction with the
Grignard installed the anisole substructure at the C2 position in near perfect
regeoselectivity  producing  a  2:1  diastereomeric  mixture  of  the  α­
hydroxylactam [175]. Lewis acid mediated reductive deoxygenation gave rise
to the 2-pyrrolidinonium ion intermediate [176] before setting the
stereochemistry predominantly in the trans  orientation  of  the  resulting  γ­
lactam [177].67,68 (Scheme 6.2)
Scheme 6.2
Reduction of the ketone in the presence of lithium aluminium hydride
followed by substitution of the amine protection via Pearlman’s catalyst gave
[178]; the diastereoisomer of Takahata’s pyrrolidine [166]. This allowed for
familiar hydroxyl elaboration to make use of Chugaev’s elimination protocol.
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Trivial amine deprotection concluded the synthesis of [26] in a 39% yield
over 8 steps from [174].67,68 (Scheme 6.3)
Scheme 6.3
In an interesting deviation from the general cyclisation theme; Greene et al. in
1999 drew upon their experience in their synthesis of (+)-preussin [180], a
related natural product, a year earlier69 and used an asymmetric 2+2
cycloaddition reaction on their route to Takahata’s cis-disubstituted
pyrrolidine [166]64 before expanding the resultant cyclobutanone.
Scheme 6.4
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Starting with (S)-1-(2,4,6-triisopropylphenyl)ethanol [181] as the chiral
auxiliary with trichlororthene; the (E)-dichloro-enol ether [182] was
successfully prepared for the addition of the aromatic. Formation of the
lithium acetylide with nbutyllithium allowed for alkylation with 4-
methoxybenzyl bromide to yield the relatively unstable acetylenic ether.
(Scheme 6.4)
Lindlar’s barium sulfate catalyst with a pyridine modifier as opposed to the
conventional quinoline, allowed for reduction to the (Z)-enol ether [183]
before diastereofacially selective 2+2 cycloaddition reaction with in situ
generated dichloroketene produced the desired dichlorocyclobutanone [184].
With the use of Tamura’s reagent [185], a Beckmann ring expansion of the
cyclobutanone [184] installed the essential nitrogen component and gave the
γ­lactam [186], which was subsequently de-chlorinated with a zinc/copper
couple. Protection of the newly establish nitrogen with benzyl chloroformate
sanctioned the reduction of the lactam’s carbonyl constituent with lithium
triethylborohydride and triethylsilane in boron trifluoride diethyl etherate.
Treatment with trifluoroacetic acid removed the chiral auxiliary appendage
and finalised the formal synthesis in a 27% overall yield.70 (Scheme 6.5)
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Scheme 6.5
In 2003 Chang et al. sought a more direct and efficient route to Takano’s key
intermediate [193]62 from trans-4-hydroxyproline [189]. Quantitative
methylation of the carboxylic acid with thionyl chloride permitted protection
of the amine with di-tert-butyl dicarbonate and tert-butyldimethylsilyl
chloride protection of the alcohol to give methyl ester [190]. Sodium
borohydride reduction with lithium chloride converted the methyl ester to the
primary alcohol which in turn allowed for Swern oxidation to form the
electrophilic target [191] for Grignard addition of the anisole group.
Treatment with trifluoroacetic acid and triethylsilane ensured deprotection of
both functional groups along with benzylic hydroxide elimination.
Restoration of the amine protection finalised the conversion to Takano’s
intermediate [193] in 8 steps and a good 56% overall yield.71 (Scheme 6.6)
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Scheme 6.6
Sudalai’s 2009 elegant parallel strategy for the formation of both (-)-deacetyl
anisomycin [4] and Akita’s cyclisation precursor [148], employed a proline-
catalysed α­amination/α­aminoxylation with a sequential Horner­Wadsworth­
Emmons olefination.
Scheme 6.7
Whilst both routes started with the same 3-(4-methoxyphenyl)-propanal [194]
the α­amination used dibenzyl azodicarboxylate as the source of the nitrogen
whereas the inclusion of nitrosobenzene enabled the α­aminoxylation.72
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On addition of L-proline, the newly created enamine formed a chair-like
conformational transition state [195] as the DBAD approached from the re-
face with the assistance of the hydrogen bonding from the carboxyl group.
Formation of the carboxypyrrolidinium ion caused the transitory ring to
collapse  with  molecular  rearrangement  to  give  the  α­aminoaldehyde
[196].72,73 (Scheme 6.7)
Scheme 6.8
Reaction  of  the  α­aminoaldehyde [196] with an in situ formed ylide of
trimethyl phosphonoacetate increased the carbon chain length by installing
the trans double bond [197], while osmium catalysed stereoselective
dihydroxylation yielded the predominant syn product [198] in a 7:1
relationship to the anti artefact.
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Scheme 6.9
Raney nickel high pressure reductive cyclisation with an ethanol reflux
successfully gave the lactam [199] in a modest 66% yield, and (-)-deacetyl
anisomycin [4] was completed with a borane dimethyl sulfide complex
reduction of the amide carbonyl in 45% overall yield.72 (Scheme 6.8)
Sudalai’s second strategy followed very similar reaction protocols, however
for the α­aminoxylation, the electrophilic component was nitrosobenzene and
D-proline was used as the catalyst. Reduction of the anilinoxy [200] with
copper(II)acetate in ethanol revealed the hydroxyl [201] and identical
dihydroxylation induced cyclisation as the single lactone diastereomer [148]
of Akita’s 1999 synthesis in 30% overall yield.72 (Scheme 6.9)
The most recent total synthesis of (-)-anisomycin was reported by Lui et al. in
2012. Whilst the strategy bore echoes of earlier syntheses, their efficiency and
ultimate success was in finding a solution to the historical problem of
multiple alternating protection steps. The use of acetic anhydride in the first
step would not only suffice as amine protection on the D-tyrosine starting
material, it would also serve as an integral unit for a key reaction during the
synthesis and end as a final motif in the target molecule. Reduction of the
methyl ester to the primary alcohol and then ultimately onto the aldehyde
[202] allowed for conversion to Ramirez’s dibromoölefin,74 before treatment
under the Corey-Fuchs protocol75 furnished the propargyl alcohol [203].
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Partial reduction of the triple bond with Lindlar’s catalyst gave the (Z)-olefin
[204] within the carbon tether, almost identical to that of Jegham [31], save
for the amine protection.76 (Scheme 7.0)
Scheme 7.0
Sharpless asymmetric epoxidation of the allylic alcohol [204] followed by
conversion to the mesylate enabled a thermo-induced intramolecular cascade
to form the oxazoline intermediate with the terminal oxirane. This key
reaction not only inverted the C3 position to the correct stereochemistry but
under acid hydrolysis also installed the acetate beta to the benzylic
methylene. The epoxide [206] also succumbed to acid hydrolysis to give the
diol and Boc protection of the amine allowed for chemoselective mesylation.
The recognizable syn substituted carbon backbone [207] was subjected to
cyclisation via sodium hydride in dimethyl formamide before Boc
deprotection concluded the synthesis in 11 steps with a 9% overall yield.76
(Scheme 7.1)
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Scheme 7.1
Whilst the natural levorotatory anisomycin [1] and (-)-deacetyl anisomycin
[4] contain the important biologically active conformations, several groups
have reported syntheses of their enantiomers and diastereoisomers. The first
synthesis of unnatural (+)-anisomycin [1a] was reported by Meyers and
Dupre in 1987. The approach for this enantioselective route was drawn from
the groups’ previous study into the synthesis of (+)-metazocine77 where a
tert-butylformamidine tether was used to guide the metal-halogen exchange
alkylation. The pyrrolidine formamidine was subjected to t-butylithium to
give the α­lithioanion [208], which in turn allowed for alkylation with anisole
chloride to form the 2-aryldihydropyrrole formamidine [209] in a 77:23 ratio
together with an undesired regio-isomer [210]. Treatment of this mixture with
hydrazine ensured destruction of the isomer and produced 2-(p-
methoxybenzyl)-3-pyrroline [211] in 53% yield and 95% ee. Conversion of
the alkene to (+)-anisomycin [1a] followed Hall’s43 route to the natural
product [4] and completed the synthesis.78 (Scheme 7.2)
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Scheme 7.2
Rao et al. published a formal synthesis of (+)-anisomycin [1a] in 2005 using
a fully protected O-isopropylidine D-mannitol [212] starting material.
Conversion to the terminal epoxide [213] over 6 steps in 34% yield enabled
Grignard addition, similar to that of Lin et al.46 to attach the aryl moiety
[214]. Translation of the newly formed hydroxyl group to the azido
functionality via the mesylate permitted further manipulation to give the Boc
protected amine and the customary pre-cyclisation cognate [215].
Debenzylation and conversion to the mesylate followed by trifluoroacetic
acid to remove the acetal protection allowed formation of (+)-deacetyl
anisomycin [5] with triethylamine in methanol in an 11% overall yield.79
(Scheme 7.3)
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Scheme 7.3
The most recent synthesis of (+)-anisomycin [1a] was reported by
Maarseveen et al. in 2011 following a lengthy study of copper catalysed
propargylic substitution reactions. Enantioselective amination of the
propargyl ester [217] with o-anisidine, cuprous iodide, Hünig’s base and a
chiral 2,6-bis(oxazolinyl-diphenyl)pyridine or PyBOX ligand [216] fashioned
over 6 steps afforded the benzyl-substituted propargylic amine [218] in 59%
yield and 90% ee.
Scheme 7.4
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Treatment with iodo-benzene diacetate in acetonitrile and methanol ensured
oxidative removal of the anisidyl subunit followed by Boc protection of the
primary amine [219]. Formation of the aminoallene [220] under Crabbé
reaction81 conditions allowed for formation of the protected 2-(p-
methoxybenzyl)-3-pyrroline [211] via gold-catalysed ring closure in 7%
overall yield.80 (Scheme 7.4)
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2. Results and Discussion
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2.1 Introduction to results and discussion.
The Parsons group have had a long tradition in the synthesis of natural
products at Sussex University including (-)-Kainic acid,82 Galbondolide B,83
(-)-Tetrahydrolipstsatin,84 (±)-Anatoxin A,85 and Brevioxime.86 We wished to
add to this impressive list of natural compounds with a total synthesis of (-)-
anisomycin [1], a biologically active alkaloid. The intentions of this research
project are to:
1. Utilize the oxazolidinone as the synthetic starting material and
attempt to improve upon any of the sequences in the multigram
preparation.
2. Develop an efficient and practical synthesis of (-)-anisomycin.
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2.2 Investigating the synthesis of (-)-anisomycin.
2.2.1 Formation of the Oxazolidinone [221].
In the continuation of developing a program of concise and efficient
syntheses of biologically important molecules, successive members of the
Parsons group have been working towards a generic chiral starting material
with sufficient inbuilt functionality that it can be taken forward to different
target alkaloids. This oxazolidinone precursor [221], originally developed by
Greenwood87 together with modifications by Murray can be fashioned from
the inexpensive, commercially available amino acid derivative trans-4-
hydroxy-L-proline [222] in multigram quantities.
Figure 1.7
Fischer–Speier esterification of trans-4-hydroxy-L-proline [222] with thionyl
chloride in methanol led to the pyrrolidine methyl-ester hydrochloride salt
[223] followed by subsequent Boc protection of the secondary amine [224] in
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95% yield. Transformation of the lone hydroxyl to give the mesyloxy-
prolinate [225] allowed for a two step process to install the essential double
bond at the crown of the molecule. Treatment of the prolinate [225] with an in
situ generated anionic phenyl-selenide species ensured displacement of the
newly established mesylate together with concomitant solvent induced
transesterification. Oxidation of the selenide [226] with hydrogen peroxide
and successive syn elimination gave the desired alkene [227] in 62% yield.
Scheme 7.5
The resultant ethyl ester [227] was reduced to the primary alcohol [228]
originally with lithium aluminium hydride but Murray showed that the
reduction could also be performed using diisobutylaluminium hydride and
would have the advantage of negating the difficult work-up procedure and
decomposition of the product. This reduction step has now been modified
further with the use of 3 equivalents of sodium borohydride in dry THF and
methanol. Although the reaction proceeds at a slower rate with this favoured
lewis acid, sodium borohydride is a significantly milder reducing agent than
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either LiAlH4 or DiBAL and has delivered an increase in yield by a further
6%.
The final step of ring closure to complete the oxazolidinone [221] was
achieved by reaction of the alcohol [228] with (diethylamino)sulfur trifluoride
and gave the bicyclic compound [221] as viscous pale yellow oil in 75%
yield. (Scheme 7.5)
Whilst conversion rates in the initial route of the Boc protected methyl ester
[224] to the olefin [227] were of appreciable quantity, the use of the highly
toxic selenium reagents and the exothermic volatility of the procedure during
scale up necessitated an alternate procurement of the alkene [227].
Scheme 7.6
In an adaptation of both Garegg’s88 method for conversion of hydroxyl
groups to iodo groups in carbohydrate chemistry and Viaud’s89 synthesis of a
chiral spiranic aminochroman derivative, treatment of the methyl ester [224]
with triphenylphosphine, iodine and imidazole afforded the cis crystalline
iodo-pyrrolidine [229] in a very good 82% yield. Separation of the
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stereoisomers was unnecessary and reaction of diazabicyclo-[5.4.0]-undecene
with the crude mixture yielded an 8:1 ratio of regio-isomeric 3,4- [231] and
4,5-dihydro-prolines [232] in favour of the desired 3,4-product [231].
(Scheme 7.6)
2.2.2 Retrosynthesis of (-)-Anisomycin [1].
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The strategy for the construction of (-)-anisomycin [1] was to set the three
stereocentres at the outset of the synthesis then manipulate each of the limbs
independently to their individual final architecture. With the amine and the
masked alcohol mutually protected within the cyclic carbamate, the double
bond of the advanced precursor [221] could be converted to the desired
epoxide [234] by taking full advantage of its prejudice to form endo face
compounds. Regioselective fragmentation of the ring would then complete
the molecular stereochemistry followed by protection of both new functional
groups [235]. Carbamate ring opening followed by amine protection would
allow unencumbered access to the primary alcohol [235a] and subsequent
conversion of this to a suitable leaving group [235b] would enable addition of
the aryl moiety. Selective deprotection at the C3 position and conversion to
the acetate [235c] would leave global deprotection to yield the natural
alkaloid [1]. (Scheme 7.7)
Scheme 7.7
2.2.3 Epoxidation of the oxazolidinone [221].
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Previously, both Greenwood87 and Murray90 had independently investigated
the stereoselective nature of the alkene [221] and found that not only did a
series of [2+2] photocycloadditions give impressive diastereofacial selectivity
but electrophilic addition demonstrated the same bias. Pyne et al; whose ring
closing metathesis is the only other documented route to the oxazolidinone
[221], observed a similar pattern when treatment of the alkene [221] with
osmium tetroxide revealed a syn diol.91 Pyne suggested that the “butterfly”
type conformation adopted by the oxazolidinone [221] ensured that the
pseudo-axial protons at carbons 2 and 5 presented a steric hindrance to the
exo face. However, a theoretical molecular model study by Viseux92 in the
same year concluded that an inequality in the distribution of electron density
surrounding the π­bond favoured addition to the internal face.
Figure 1.8: Pyne’s pseudo-axial hindrance protons and Viseux’s
representation of the oxazolidinone [221] HOMO90
Epoxidations to the oxazolidinone [221] have previously been carried out by
both Greenwood93 and Murray90 on their respective routes to members of the
kainoid amino acid family. Although both were successful in achieving the
desired product [234]; varying degrees of success in terms of yield were
experienced. Greenwood’s methods of using mCPBA and isolated
dimethyldioxirane were both low yielding and impractical for scale-up
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quantities respectively. Murray’s adaptation of a Shi et al. in situ generated
DMDO however, obtained the epoxide [234] in an impressive 77% yield. 94
Our strategy necessitated formation of the epoxide [234] and whilst we felt
Murray’s version of the in situ generated DMDO had merit with regard to
delivering multigram yields, the precise and critical pH control together with
the laborious and prolonged reagent additions demanded a less complex
solution. Hashimoto95 had investigated the use of in situ generated DMDO
from Oxone® and acetone for the epoxidation of olefins and his biphasic
system did not require the use of a phase transfer catalyst nor the toxic
acetonitrile of the Shi method. Hashimoto considered DMDO to be more
lipophilic than the parent ketone and therefore likely to migrate into the
organic phase even in the absence of a PTC. 95 We explored Hashimoto’s
method and noted that although he had used several different organic solvents
and toluene had showed early promise in his methodology, ethyl acetate
clearly produced the best conversion rates.
Figure 1.9: Formation of DMDO and epoxidation of Epoxide [234].
73
This was mirrored in our experiments whereby the ethyl acetate led to yields
in the high seventy percent range while DCM and toluene gave significantly
lower yields. (Table 1.1)
Scheme 7.7
Epoxide [234] was purified and revealed as white Mayan profile pyramidal
crystals in a maximum 81% yield whereby its structure was clarified by way
of x-ray analysis.
Table 1.1: Conditions used to form epoxide [234].
We consider this method of epoxidation of the oxazolidinone [221] an
advancement on the Murray adapted Shi protocol, not only because the
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practical nature of the reaction simplifies the procedure, but it delivers an
increase in final yield and removes the toxic element from the reaction. It was
interesting to note that with this epoxidation method a small amount of the
diastereoisomer [236] was isolated indicating that the diastereofacial
selectivity is not 100% exclusive. (Scheme 7.7)
Figure 2.0: X-ray structure of epoxide [234].
2.2.4 Regio-selective ring opening of epoxide [234].
With a reaction that allows us to form multigram quantities of the pure
epoxide [234] our attention turned to the regio- and stereoselective opening of
the newly formed ring. We considered that benzyl alcohol would not only
serve as a suitable nucleophile, but on successful opening there would be
inbuilt oxygen functionality provided at C4 in the target compound, with the
added bonus that this delivered oxygen functionality would carry with it its
own protection.
Smith et al. showed in their total synthesis of (+)-Jatropholones A [239] that a
simple acid catalysed ring opening of cyclopentene oxide [237] with benzyl
alcohol96 was an almost a perfect mimic of our system. (Scheme 7.8)
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Scheme 7.8
We were confident that the rear side attack of the benzyl alcohols would
occur at the least hindered side of the epoxide [234] to give the three correct
contiguous stereocentres of the final compound. Whilst Smith enjoyed a 97%
conversion rate, 96 fragmentation of our epoxide [234] was unsuccessful even
when conducted in a succession of organic solvents. After futile attempts to
open the epoxide [234] with sodium hydride and benzyl alcohol in THF we
considered the use of group three elements as catalysts as the use of lewis
acids to promote the epoxide cleavage is well documented. Posner
demonstrated that a range of nucleophiles, including benzyl alcohol, coupled
with catalytic amounts of aluminium oxide was successful in opening a
variety of symmetric and asymmetric epoxides;97 again all attempts to open
our epoxide [234] failed.
Montgomery et al. used an alternate Lewis Acid to open a similar epoxide
system to Smith and we were optimistic that this electron acceptor would
work for us.98 We adapted Montgomery’s procedure and boron trifluoride
diethyl etherate in benzyl alcohol produced an 8:1 mixture of regioisomers in
favour of the desired alcohol [240]. (Scheme 7.9)
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Scheme 7.9
Figure 2.1: X-ray structure of opened epoxide [240].
Optimisation of the reaction dictated that a minimum of 33 equivalents of
benzyl alcohol were needed to ensure high yields and on careful purification
and recrystalisation a white needle-type crystalline solid was revealed.
(Figure 2.1)
2.2.5 Carbamate ring opening and amine protection.
With the second step of the synthesis completed we reconsidered the
retrosynthesis with regards to the protection of the new hydroxyl group [240].
In an attempt to preserve the efficiency of the synthesis we took the view that
once the carbamate ring was opened, the reactivity of the newly exposed
primary alcohol would take precedent over the secondary alcohol, therefore
protection would be unnecessary. Lithium hydroxide mediated hydrolysis
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gave the 1,3-diol [242] cleanly as a white powder in 95% yield.99,100 (Scheme
8.0)
Scheme 8.0
A series of crystallisations in various solvents successfully concluded in
growing crystals suitable for x-ray clarification. (Figure 2.2)
Figure 2.2: X-ray structure of 1,3-diol [242].
With the subordinate ring cleaved and ready access to the primary alcohol
secured, a suitable amine protection group was required before manipulation
of the primary alcohol could begin. The protection group required would need
to satisfy a select criterion in that it would not only need to be easy and
practical to install and return high yields, but it would be resilient enough to
endure all of the subsequent reaction conditions to the end of the synthesis
and then be selectively removed simply and efficiently. A benzyl carboxylate
group was chosen and benzyl chloroformate under Schotten-Baumann
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conditions101 gave the N-protected-1,3-diol [243] in an excellent 90% yield.
(Scheme 8.1)
Scheme 8.1
Although the successful addition of the benzyl carboxylate to form the
carbamate [243] in high yields was a welcome step forward, with it came the
inherent problem of the compounds ability to form rotamers and its obscuring
effect on the clarity of the NMR analysis. We were confident that the desired
N-protected 1,3-diol [243] had been secured as the general structural entities
of the molecule were able to be identified despite the doubling and broad
peaks in the NMR spectra; coupled together with the ancillary data of a
correct accurate mass and the significant peaks in the IR spectra. In an
attempt to resolve the quality of the NMR data we undertook a series of
variable temperature NMR experiments ranging from 30oC to 100oC, the
results however were only of limited success. Finally we also subjected the
newly formed pyrrolidine diol [243] to catalytic hydrogenation under Pd/C/H2
conditions which successfully returned the parent 1,3-diol [242].
2.2.6 Attempted introduction of the anisole appendage.
It was envisaged that conversion of the primary alcohol into a suitable leaving
group would allow for attachment of the methoxyphenyl appendage without
compromising the stereochemistry at C2. Following treatment of the N-
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protected 1,3-diol [243] with mesyl chloride, an unexpected cyclisation took
place. Instead of the expected terminal mesylate product [235], reformation of
the bicyclic mono-protected trans diol [240] resulted. The same cyclisation
product was also observed when tosyl chloride was used.102 (Scheme 8.2)
Scheme 8.2
Although the synthetic retreat was both unexpected and interesting, in that it
was not envisaged that the carboxylate would undergo intramolecular
participation when choosing the amine protecting group, neither facilitated
progression towards the target alkaloid [1]; therefore an adjustment to the
addition step was required.
Sharpless had previously shown that cyclic sulfates were capable of reacting
in a similar ring opening manner to epoxides.103,104 Whilst Sharpless was
successful in opening many different 1,2-diol systems with selective external
nucleophiles, Denmark105 reported successful formation of a 1,3-diol derived
cyclic sulfate which was subject to attack from an internal nucleophile, thus
we were optimistic that the formation of a six membered cyclic sulfate from
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our 1,3-diol [243] would share the same auspicious properties as its vicinal
cousins.
Treatment of 1,3-diol [243] with thionyl chloride in carbon tetrachloride was
monitored by TLC and the formation of the two chiral cyclic sulfites were
identified [247] and [248]. All attempts to separate the diastereoisomers by
column chromatography for data analysis failed due to rapid decomposition,
however as both isomers were to be oxidised to the cyclic sulfate [249] the
crude mixture was taken forward without purification. (Scheme 8.3)
Scheme 8.3
Even though Denmark’s conversion of sulfite to sulfate required expensive
stoichometric quantities of ruthenium tetroxide the reaction still delivered
good yields. Sharpless however, developed a far more parsimonious
ruthenium trichloride catalytic system with sodium periodate as the
stoichometric commodity. This method worked well in our system and the
cyclic sulfate [249] was delivered in a 77% yield over the 2 steps.103,104,105
(Scheme 8.3)
As Sharpless had reported that his 1,2-diol derived cyclic sulfate would
succumb to attack from an aryl Grignard reagent,103 it was hoped that this
would also be true with an anisole Grignard on our 1,3-diol arrangement.
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Treatment with freshly prepared p-methoxyphenylmagnesium bromide in
diethyl ether disappointedly proved that this was not the case. A small series
of different anisole Grignard reagents was tested which also failed to open the
ring; interestingly a small amount of the mono-protected trans diol [240] was
recovered when p-methoxyphenyl magnesiumbromide was used in THF.
(Table 1.2)
Table 1.2
2.2.7 Revised addition of the anisole appendage.
Following the second return to the mono-protected trans diol [240] an
adaptation to the cyclic sulfate route was necessary. It appeared clear that the
carbamate moiety was intrinsic in the re-cyclisation process to [240]
therefore; formation of a cyclic sulfamidate [250c] would mitigate the
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reactive carbonyl target of the benzyl ester. This however, would necessitate
pre-protection of the exposed crown hydroxyl group. (Scheme 8.4)
Scheme 8.4
For the sake of completeness and due to the formation of the 1,3-diol [242] in
multigram quantities, we attempted formation of the cyclic sulfamidite [251],
using the same method as for the N-protected-1,3-diol [243] described
previously, on the naked diol [242]; reasoning that the unprotected secondary
amine would be more reactive than the secondary alcohol. Unfortunately our
logic was not rewarded. (Scheme 8.5)
Scheme 8.5
83
Treatment of mono-protected trans diol [240] with tert-butyl dimethyl silyl
trifluoromethanesulfonate in dichloromethane and two equivalence of 2,6-
lutidine gave the dihydroxy protected oxazolidinone [252] in 79% yield. As
the cyclic carbamate ring opening protocol had already been established
previously in the synthesis to give high yields of the 1,3-diol [242], we saw
no reason to alter this on the new silyl oxazolidinone [252].
Scheme 8.6
Whilst the lithium hydroxide in ethanol procedure was once again successful
in opening the oxazolidinone’s cyclic carbamate ring, the highly basic
solution was remarkably efficient in the total cleavage of the silyl protection
group, thus returning the earlier 1,3-diol [242], albeit in excellent yield.
(Scheme 8.6)
With the inability of the silyl protection to remain in place it was hoped that a
tetrahydropyran group would remain stable under the harsh hydroxide/ethanol
conditions. Weiss et al’s synthesis of prostaglandins and their congeners
successfully employed the use of tetrahydropyran protecting groups on both a
secondary alcohol and a carboxylic acid group on a cyclopentenone
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intermediate.106 Their procedure of 3,4-dihydro-2H-pyran in dichloromethane
with p-toluenesulfonic acid monohydrate unfortunately returned only the
mono-protected trans diol [240] starting material (Scheme 8.7) regardless of
equivalence or solvent. (Table 1.3)
Scheme 8.7
Table 1.3
Grieco107 used a slightly different procedure for tetrahydropyranylation of a
series of hydroxyl groups on different molecular systems with quantitative or
near quantitative conversions on each. Whilst accepting that p-toluenesulfonic
acid was superior as a catalyst when measured against hydrochloric acid,
phosphoryl chloride and boron trifluoride diethyl etherate, he reported that the
use of freshly prepared pyridinium p-toluenesulfonate was more efficient and
delivered greater yields in the preparation of alcohol derived THP ethers.102
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Treatment of p-toluenesulfonic acid with dry pyridine in dichloromethane
gave a white crystalline solid which was added without delay to the mono-
protected trans diol [240] with 3,4-dihydro-2H-pyran in dichloromethane.
The reaction was monitored via TLC over 4 hours and returned the two
diastereoisomers of the desired pyran [255] and [256]. (Scheme 8.7)
After purification and recrystalisation from diethyl ether, small white needle
crystals in an excellent 96% yield were harvested and subject to x-ray
crystallographic analysis. (Figure 2.3)
Figure 2.3: X-ray structure of tetrahydropyran oxazolidinone [256].
The mixture of the two diastereoisomers of the tetrahydropyran oxazolidinone
[255] and [256] were subjected to the same lithium hydroxide ring opening
protocol which gave the 1,3-diol [242] previously and recovered the desired,
although inseparable, diastereoisomeric mixture of the pyrrolidine alcohol
[257] in an 86% yield. (Scheme 8.8)
Scheme 8.8
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Employing the previous method used to generate the cyclic sulfite on the N-
protected-1,3-diol [243], the diastereoisomeric mixture of pyrans [257], were
treated with thionyl chloride in carbon tetrachloride over 24 hours. The
reaction was monitored via TLC but no indication of cyclic sulfamidite [259]
formation was found. (Scheme 8.9)
Scheme 8.9
It was clear from our results that the cyclic sulfate route to facilitate the
addition of the anisole moiety was futile and it was therefore abandoned. We
took heart that we had successfully protected the trans diol and were able to
expose the primary alcohol whilst maintaining the integrity of the three
contiguous centres along with the diol protection and returned to our
retrosynthetic strategy, confident that correct manipulation of the primary
alcohol would smooth the progression to the next step.
In an effort to reduce the number of synthetic steps we briefly explored the
possibility of not only opening the subordinate ring but concomitantly
protecting the amine under the same reaction. Kerns et al. reported a tandem
opening and methyl carbamate protection of a ring-fused D-glucose
oxazolidinone derivative with cesium carbonate in methanol.108
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Scheme 9.0
Whilst this protocol showed hesitant promise in our system, with crude
analysis showing the correct mass and clear methoxy peaks in the NMR at
3.75 ppm, the yield was disappointingly low. An analogous procedure was
attempted with the addition of benzyl alcohol in the hope of securing the
benzyl carbamate [261] but this unfortunately proved to be a futile endeavour
and only ever delivered trace quantities of the equivalent methyl product
[260]. (Scheme 9.0)
Scheme 9.1
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With the benzyl failure and the low yield of the methyl carbamate protection
[260], maximum 9%, we abandoned this route in favour of the tried and
tested lithium hydroxide in ethanol technique to deliver alcohol [257] in an
86% yield of inseparable stereoisomers. (Scheme 9.1)
We repeated the Schotten-Baumann conditions from earlier in the synthesis
which gave the N-protected-1,3-diol [243] in high yields and was rewarded
with alcohol [261] in an 88% yield. (Scheme 9.1)
2.2.8 Aldehyde formation.
We now chose to convert the primary alcohol of [261] to the aldehyde [265]
as this would give several options with which to attach the anisole group. A
limited series of oxidation reactions were undertaken to establish which
procedure would give the best results for our system.109-113 (Table 1.4)
Table 1.4
Joullie et al. used a trifluoroacetic anhydride variation of the Swern oxidation
with good success on their intermediate alcohol [262] in a total synthesis of
(-)-Detoxinine [264].109 (Scheme 9.2)
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Scheme 9.2
The intermediate alcohol [262] in the Joullie synthesis bore a close
resemblance to our system, but whilst the oxidation reaction delivered an
88% yield for [264], the same procedure gave aldehyde [266] in a modest
58% maximum yield for us.109 Purification of the aldehyde [266] proved to be
a difficult undertaking due to its propensity to decompose during column
chromatography.
Although the formation of the aldehyde [266] would finally allow the
addition of aryl group, this key reaction would prove later in the synthesis to
have compromised the stereochemistry at C2 whereby it is believed that the
inclusion of triethylamine over the more sterically hindered Hünig’s base,
N,N-diisopropylethylamine, induced epimerisation alpha to the newly formed
carbonyl. Whilst the correct mass was determined at m/z 462.18 as its
sodiated ion and the identity of the all important aldehyde peaks between 9.4
and 9.8 ppm in the NMR spectrum; the rest of the NMR spectrum proved
difficult to accurately assign due not only to the diastereoisomers of the
tetrahydropyran groups and notwithstanding the fragile stability of the
compound itself, but also for the benzyl carboxylate’s penchant to broaden
the peaks of the spectrum because of the rotameric effect. (Scheme 9.3)
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Scheme 9.3
As we were not aware of the stereochemical compromise at the C2 position of
the aldehyde [266] at the time, we proceeded forward to the next step of the
synthesis.
2.2.9 Successful introduction of the anisole appendage.
The addition reaction required the instalment of a p-methoxyphenyl moiety;
therefore the obvious choice was a derived anisole-halogen reagent. This
would allow for the option to create a Grignard nucleophile or to exploit a
metal-halogen exchange reaction. The latter method was chosen due in no
small part to the Grignard failures earlier in the synthesis and the wish to try
new reactions. Bailey and Punzalan114 conducted a study to find a convenient
and general method of preparation of alkyllithium reagents by lithium-iodine
exchange. In an adaptation of their methods p-bromoanisole was treated with
nbutyllithium in THF and added to the aldehyde [266]; this resulted in the
attachment of the major appendage and pyrrolidine [267] was extracted in a
31 % yield. The same reaction was undertaken with p-iodoanisole as the aryl-
halogen reagent and delivered the identical diastereoisomeric pyrrolidines
[267] in a 44% yield. (Scheme 9.4)
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Scheme 9.4
With the new pyrrolidine compounds [267], containing the additional chiral
centre of the pyran protecting group, together with the newly formed benzylic
alcohol’s undefined stereochemistry; separation of the diastereoisomers
proved to be impossible by column chromatography, and with the carbamate
group’s persistence in obscuring the 1H NMR spectra, clear and definitive
NMR data analysis was not possible. It was clear however, that the
anisomycin skeletal framework was now in place as the significant
architectural groups could be identified with ease. An obvious methoxy peak
of the anisole group was recorded at 3.77 ppm together with the benzyl meta
and ortho peaks of the same group which were unambiguous at 6.92 and 7.29
ppm. The methanediyil of the protective pyran group were visible at the lower
end of the spectra, 1.50-1.90 ppm and the aromatics of the benzyl ether and
benzyl carboxylate groups could be seen at 7.29-7.37 ppm. The absence of
the aldehyde peaks [267] at 9.4 and 9.8 ppm indicated that all of the starting
material had been consumed, however, whilst the pyrrolidine hydrogens, the
chiral pyran and the new benzylic proton at the addition site were generally
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identifiable though the HSQC NMR and via 1H integration, correct individual
assignments was not possible.
This data coupled with the correct accurate mass recording and, from a
synthesis progression standpoint, the redundant necessity of diastereoisomeric
separation, allowed us to concentrate on removing the hydroxyl remnant of
the parent aldehyde.
Figure 2.4
2.2.10 Reduction of benzylic hydroxyl group.
Mayr, in 1997, had reported an investigative study into the ionic reduction of
a series of alcohols and ketones with triethylsilane and trifluoroacetic acid
solutions115 and we were optimistic that this system could serve to reduce the
benzylic alcohol to the methylene. As the tetrahydropyran protecting group
was slated for removal at the next step in the synthesis so that the resultant
alcohol could receive the final architectural group, we were hopeful that
silane/brØnsted acid treatment would effect the tandem elimination of this
group too.
Scheme 9.5
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Treatment of the mixture of alcohol diastereomers [267] with excess
triethylsilane and trifluoroacetic acid confirmed that our optimism was well
placed as the benzylic alcohol and the tetrahydropyran groups were removed;
however, the acidic solution also efficiently dispatched the amine protection
and delivered the all but naked pyrrolidinol [268] in a maximum 81% yield.
(Scheme 9.5)
With the removal of the benzylic alcohol, the carboxylate and the
tetrahydropyran diastereomers, we  took  the  opportunity  to  establish  an  [α]D
value for the pyrrolidinol [268] to compare with the literature values of (-)-
anisomycin [1]. Kibayashi reported a value of [α]D20 -30o (c 0.3 EtOH)49 and
Hall  reported  [α]D26 -26o (c 0.15 MeOH). Whilst we had not formed the
acetoxy group or removed the benzyl ether, our [α]D23 -18.006o (c 0.1 MeOH)
value appeared to bode well although we were still not aware at the time of
the inversion of the C2 stereocentre.
2.2.11 Introduction of the acetoxy group.
With the pyrrolidinol [268] exposed as its free base, the conversion of the
lone alcohol to the acetoxy group would have to defer to the reinstatement of
the amine protection. The Schotten-Baumann conditions with benzyl
chloroformate from earlier in the synthesis were thus re-employed to again
establish the carbamate protection and gave the alcohol [269] in 78% yield.
(Scheme 9.6)
Scheme 9.6
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To furnish the remaining architectural component on the solitary crown
hydroxyl group to fulfil the anisomycin framework, a simple and efficient
method of acetylation was required. Chandler et al. en route to the potent
anti-influenza compound, 4-guanidino Neu5Ac2en [272], performed a global
acetylation of the key intermediate [270] in the synthesis and returned an
impressive 96% yield on this penta-acetylation.116 (Scheme 9.7)
Scheme 9.7
The Chandler protocol was translated to the alcohol [269] and the acetoxy
pyrrolidine [273] was delivered in a very good 84% yield. (Scheme 9.8)
Scheme 9.8
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2.2.12 Global deprotection.
The concluding step in the synthesis was to remove the remaining protecting
groups to unveil the final compound. Whilst both the benzyl groups were
different and in turn protecting different functional groups, they were
equivalent in their inability to resist purging via catalytic hydrogenation. The
acetoxy pyrrolidine [273] was treated in ethanol with 10% palladium on
charcoal under an atmosphere of hydrogen over 4 days to give the final
compound [274] as a white powder in 93% yield and 9.4% overall yield.
(Scheme 9.9)
Scheme 9.9
2.2.13 Authentication of the final product [274].
With the pure final compound [274] in hand we set about confirming its
authenticity as the natural alkaloid [1]. A clean accurate mass was recorded of
m/z 266.1384 as the protonated ion and the NMR spectra revealed peaks for
the methyl of the benzyl methoxy at 2.16 ppm, the methyl of the acetoxy at
3.74 ppm and the benzylic ortho and meta protons at 6.80 and 7.05 ppm all of
which were concurrent with the general literature data values when recorded
in deuterated chloroform. However, the peaks indicated for the pyrrolidine
hydrogen atoms and the benzylic methylene were significantly skewed as to
warrant further investigation. An [α]D21 -2.8002o (c 1.0 MeOH) value for our
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anisomycin [274] did not compare favourably with the natural product [1],
[α]D25 -29.0o (c 1.0 MeOH), thus a further incentive to establish the correct
identity of our final compound [274].
The literature data values for the 1H and 13C NMR in the different
publications of the total synthesis of (-)-anisomycin [1] vary due to the final
products data being collected in different deuterated solvents and the use of
equipment with varying degrees of antiquity and operating frequencies
ranging from 60 MHz–500 MHz for 1H and 20 MHz–125 MHz for 13C.
Figure: 2.5 1H NMR spectra of Anisomycin [274]
In an attempt to mitigate any disparity, NMR data was collected for our final
product in both deuterated chloroform and deuterated methanol and the
results compared with the data from comparable equipment. Ham et al.33
recorded clear and comprehensive 1H and 13C NMR data for (-)-anisomycin
[1] in CDCl3 whilst Lin46 and LeFevre117 recorded 1H and 13C NMR data
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respectively in CD3OD. This comparison left little, if no doubt to the
conclusion that our compound [274] was not that of the natural alkaloid [1].
To remove any lingering reservations, we obtained a pure and authentic
sample of (-)-anisomycin [1] and the contrast was absolute in both CDCl3 and
CD3OD. (Figure 2.5)
Figure: 2.5 1H NMR spectra (-)-anisomycin [1] in CDCl3.
While all of the data clearly indicated that we had successfully constructed
the anisomycin skeleton with the correct ancillary architecture, we drew the
conclusion from both the NMR and the polarimetry data that one or more of
the chiral centres must be guilty of the discrepancy. With the specific rotation
of [274] as a low negative value we tenuously suspected that the chirality of
only one centre had been affected. We re-evaluated our route from the
oxazolidinone [221] through to our final product [274] in an attempt to
discern at which point and under which reaction conditions the
stereochemical compromise could have taken place.
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The analytical data of the oxazolidinone [221] was identical to that recorded
in the literature and with the C2 chiral centre bound within the cyclic
carbamate ring we took this as the starting point. The epoxide had a specific
rotation  value  of  [α]D22 -8.1027o (c 1.9 CHCl3) and good NMR spectra
assignment, however, the x-ray crystallographic data left no doubt as to the
configural orientation of the stereochemistry. The following compound, the
mono-protected trans diol [240] was the first of our molecules to contain
within it all three of the correct stereo centres. We established a specific
rotation value of [α]D23 -10.249o (c 1.0 CHCl3) and again the effort involved
in enticing crystal growth paid dividends in the ability to gain valuable x-ray
crystallographic data. The mono-protected trans diol [240] was subject to
both subsidiary ring opening to give the 1,3 diol [242] and hydroxyl THP
protection to give the dual protected trans oxazolidinone [254]. Yet again the
NMR data could be assigned confidently for both compounds and the luxury
of x-ray crystallographic analysis discounted any ambiguity as to chiral
alterations. As the mono-protected trans diol [240] had been subject to
relatively harsh reaction conditions with which to open the carbamate ring
and the x-ray analysis had verified that the stereochemistry of the resultant
1,3 diol [242] had remained unaltered, we saw no reason to suspect that the
identical ring opening conditions of the dual protected trans oxazolidinone
[254] would suffer any compromise in its chirality. The inseparable mixture
of the diastereoisomers from the THP group impacted significantly on the
ability to obtain clarity in the NMR spectra of alcohol [257], although
surprisingly however, the attachment of the benzyl carboxylate protection
group appeared to give a certain stability and standard assignment of the N-
protected-alcohol [261] proved to be relatively straightforward, even with
substantial rotameric broadening. To this point it was considered that any
reaction conditions that could have influenced the C2 stereocentre were
unlikely; although the inability to secure sufficiently clear NMR data of the
alcohol [257] and to some degree that of the subsequent tri-protected alcohol
[261] to ascertain it definitively, was unfortunate if not frustrating. We did
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however on balance, now believe that the aldehyde conversion was most
likely  the  culpable  reaction. Chiral  lability of α­amino  aldehyde derivatives
during fabrication, storage and column chromatography is well documented
in the literature, 118-121 and upon post mortem of the synthesis coupled with
hindsight; the use of the more sterically hindered Hünig’s base in place of
triethylamine during the Swern oxidation could have alleviated the issue. As
no comprehensible analytical NMR data was obtainable for the aldehyde
[266], which could categorically determine that it was this stereocentre which
had been altered; together with the following compound [267] containing the
THP diastereoisomers, the benzylic alcohol residue from the aryl addition and
the carbamate rotamers, we felt that it would now be prudent to try to identify
conclusively the compromised centre from the final compound [274] and
work backwards through the synthesis.
We conducted a further set of more intrusive NMR experiments on
anisomycin [274], obtaining gCOSY, gHSQCAD, gHMBCAD and NOESY
spectra, and compared these with the same for the authentic sample of (-)-
anisomycin [1].
The NOESY data provided evidence that it was indeed the C2 stereocentre
which had been inverted. The (-)-anisomycin [1] NOESY spectra showed a
clear correlation involving C2-H and C3-H implying a cis relationship
between the two protons and no enhancement between C3-H and C4-H
signifying a trans geometry. (Figure 2.6)
The NOESY NMR data for anisomycin [274] unlike its natural bioactive
cousin [1] did not show any correlation between the key C2-H and C3-H,
indicating a lack of the desired cis geometry; it also showed little or no
relationship between C3-H and C4-H further confirming that this was also in
a trans configuration. (Figure 2.7)
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Figure: 2.6 NOESY NMR spectra of (-)-anisomycin [1]
Figure: 2.7 NOESY NMR spectra of (-)-epi-2-anisomycin [274]
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We were now confident that with the in-depth NMR data, accurate mass,
specific rotation and IR evidence we had correctly identified the structure and
geometry of our final product as (-)-epi-2-anisomycin [274]. Retreating
further back through the synthesis, we obtained a NOESY NMR spectra of
the pyrrolidinol [268] to further support the evidence that the C2 inversion
had taken place and to try to ascertain where in the route it had happened. The
NOESY NMR data for mono-protected alcohol [268] again showed no
relationship between C2-H and C3-H, signifying that a trans configuration
existed. (Figure 2.8)
Figure: 2.8 NOESY NMR spectra of pyrrolidinol [268]
Comprehensive determination by analysis of the NMR data any further down
the synthetic route was not possible as reported earlier, so we sought to
validate our findings by comparing the (-)-epi-2-anisomycin [274] data with
any identical compound reported in the literature. Park et al. reported the
synthesis of several anisomycin and deacetyl anisomycin derivatives from D-
tyrosine in 2005, unfortunately (-)-epi-2-anisomycin [274] was not one of the
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synthesised derivatives included in the report; although its enantiomer,
Beerboom’s suggested configuration of (-)-anisomycin6 [2] was.4,6 (Figure
2.9)
Figure: 2.9 Park et al’s enantiomer [2] of our
epi-2-anisomycin [274]
As this enantiomer should provide an identical NMR spectrum, together with
matching IR spectra and accurate mass to our final compound [274], we
sought comparison. A visual analysis of the IR spectra in Park’s publication
was not available therefore a comparison was not possible; however, there
were three of the key IR peaks reported and these values, although not exact
matches, were within a comparable range with our data. A reported HRMS
value of M+ 265.1305 was also stated in comparison to our m/z 266.1387 for
the protonated molecular ion.
We were concerned to find that the 1H NMR spectra of (-)-epi-2-anisomycin
[274] did not match that of Park’s enantiomer [2] and by some significant
margin. It was noted that the author also made no reference to the extra
multiplet peak at 3.16 ppm and the more significant singlet peak at 4.70
ppm.4 (Figure 3.0)
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Park et al’s anisomycin [2] epi-2-anisomycin [274]
Figure: 3.0 1H NMR spectrum of Park’s anisomycin [2] and
(-)-epi-2-anisomycin [274]
Park et al. also reported 3 month later in a different journal, a second series of
anisomycin and deacetyl anisomycin derivatives from D-tyrosine, including
that of (-)-epi-2-anisomycin [274].4
Anisomycin [2] anisomycin [274]
Park et al’s anisomycin [2] Park et al’s epi-2-anisomycin [274]
Figure: 3.1 1H NMR spectrum of both anisomycin [2] and
[274] enantiomers reported by Park.
We compared our final compound [274] 1H NMR data with their reported of
the same and again found substantial anomalies; however, more significantly
the 1H NMR spectra for the pair of anisomycin enantiomers from the two
publications also differed considerably.4 (Figure 3.1)
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Upon further analysis between the two publications we noted inconsistencies
in the 13C NMR spectral data for both the enantiomers [2] and [274], together
with significant differences to our spectrum. 4
2.3 Conclusion.
Our 11 step synthesis to (-)-epi-2-anisomycin successfully continues the
Parsons group program of converting the oxazolidinone precursor [211] to
different natural products and their derivatives. Whilst this particular
synthesis failed to yield the biologically active isomer, the general route holds
excellent promise to succeed to the natural alkaloid in good yield in future
work.
The oxazolidinone’s propensity to yield to excellent stereo- and regio-
selectivity is a clear advantage in obtaining the desired trans geometry for the
eventual hydroxy and acetoxy groups. The formation of the aldehyde [266]
proved to be a paradoxical poisoned chalice; on the one hand it allowed for
the addition of the aryl group after months of failures and ultimately the
completion of the synthesis of anisomycin skeleton, but on the other, the
compromised stereocentre stopped us achieving the total synthesis of the
natural alkaloid [1].
Our diligence in determining the correct structure and configuration of our
final product [274] despite the unreliability of the literature data also enabled
us to suggest where in the synthesis the inversion of C2 took place. In
hindsight, if the knowledge of the epimerisation had been known at the time
or additional laboratory time were available when the inversion had been
discovered, the reduction of the aldehyde [266] back to the parent alcohol
[257] with NaBH4 may have allowed us to investigate any chiral
epimerisation and could have enabled us to restore the integrity of the chiral
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centre. It is hoped that this work will aid any future endeavour to complete
the route to the natural alkaloid [1].
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3. Experimental
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3.1. General Experimental Procedures.
3.1.1. Reagents and Solvents.
All reactions were conducted under a nitrogen atmosphere unless otherwise
stated using oven dried glassware. Reactions requiring anhydrous conditions
were carried out using flame dried glassware under nitrogen. All starting
materials and reagents were purchased from commercial sources and were
used without any prior purification. All solvents were freshly distilled under a
nitrogen atmosphere unless otherwise stated from an appropriate drying agent
as described.
The solvents used in chromatography were subjected to rotary evaporation
before use to remove impurities.
3.1.2. NMR Spectroscopy
1H and 13C NMR spectra were recorded on a Varian VNMRS 500 MHz
spectrometer with samples run in deuterated chloroform, deuterated toluene or
deuterated methanol as a solvent at 30oC and are referenced to deuterated
chloroform, deuterated toluene or deuterated methanol internal reference
respectively. The chemical shifts for 1H NMR were recorded in parts per
million  (ppm) on  the δ  scale  and  the  coupling constants  (J) are measured in
Solvent Drying agent
Acetonitrile, dichloromethane,
benzene, ethyl acetate, Calcium hydride.
methanol.
Sodium (in the presence
Tetrahydrofuran, diethyl ether. of benzophenone)
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Hz. The chemical shifts for 13C NMR were recorded in parts per million (ppm)
on  the  δ  scale. 1H variable temperature NMR were recorded on a Varian
VNMRS 400 MHz spectrometer with samples run in deuterated toluene are
referenced to deuterated toluene internal reference. The chemical shifts for
were  recorded  in  parts  per  million  (ppm)  on  the  δ  scale  and  the  coupling
constants (J) are measured in Hz. The following abbreviations were used to
represent multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; quin, quintet;
m, multiplet; dd, doublet of doublets; ddd, doublet of doublet of doublets; dt,
doublet of triplets; app, apparent; br, broad.
3.1.3. Chromatography.
All reactions were monitored using thin layer chromatography, with the
solvent system as indicated. TLC was carried out using Partisil® K6F glass
backed plates with a 250 μm layer of 60 Å silica gel with fluorescent indicator.
Plate visualization was carried out using ultraviolet radiation (254 nm) when
necessary in combination with a phosphomolybdic acid (PMA) or potassium
permanganate.
Flash column chromatography was carried out using Merck Kiesel silica 60 Å,
(particle  size  35  –  70 μm)  eluting with  solvent  commercially available  from
Fisher Scientific or Sigma Aldrich, with the solvent system specified in the
procedure.
3.1.4. Mass Spectrometry.
Mass spectra were obtained on a Fisons VG Micromass 7070F and a VG
AUTOSPEC instrument using Electron Spray Ionisation (ESI). All spectral
data was captured by Dr. A. K. Abdul-Sada of the University of Sussex mass
spectrometry centre.
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3.1.5. Infra Red Spectroscopy.
Infra Red spectra were recorded using a Perkin Elmer 1710 Fourier transform
spectrophotometer with a Diamond Attenuated Total Reflectance attachment
with ʋmax measured in cm-1.
3.1.6. X-Ray Crystallography.
The crystallographic data was obtained on a Nonius Kappa CCD
diffractometer, Program package WinGX, Refinement using SHELXL-97,
Drawing using ORTEP-3 for Windows and provided by Dr Martyn Coles of
the University of Sussex.
All compounds detailed in the following experimental data have been
numbered to aid the reader in the identification of protons and carbons in the
relevant spectra. They do not necessarily correspond with that of the
I.U.P.A.C. guidelines.
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3.2. Synthesis of the Oxazolidinone [221]
(2S,4R)-2-carboxy-4-hydroxypyrrolidinium chloride [223]
To a stirred suspension of trans-4-hydroxy-L-proline [222] (20 g, 153 mmol)
in dry methanol (80 ml) at 0 °C thionyl chloride was added (12.24 mL, 168
mmol) dropwise under a nitrogen atmosphere. The reaction mixture was
stirred at 0 °C for a further 1 hour before warming to room temperature and
stirred for 14 hours. The solution was cooled to 0 °C and adding diethyl ether
(400 mL). The precipitate was filtered, washed with diethyl ether (2 x 100 mL)
and dried in vacuo to give the crude methyl ester [223] as a white solid (25.2 g
91%).
δH (500 MHz, (CD3)2SO) (Doubling and broad peaks as a result of rotamers)
9.77 (1H, br, NH), 5.54 (1H, s, OH), 4.47 (1H, dd, J 7.6, 10.9 Hz 4-H), 4.41
(1H, br, 2-H), 3.75 (3H, s, CO2CH3), 3.35 (1H, dd, J 4.3, 11.9 Hz 5-H), 3.06
(1H, d, J 4.3 Hz 5-H), 2.19 (1H, m, 3-H), 2.09 (1H, m, 3-H), δC (125 MHz,
(CD3)2SO) 169.6 (CO2CH3), 68.8 (C-4), 57.9 (C-2), 53.7 (C-5), 53.4
(CO2CH3) 37.4 (C-3). IR 3323, 2955, 2699, 1741, 1592, 1440 cm-1; HRMS
(ESI) calcd [M+H] m/z C6H12NO3 146.0817, found 146.0811. Spectroscopic
data identical to literature values.90
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(2S,4R)-4-Hydroxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-
methylester [224]
To a stirred suspension of the resulting crude methyl ester [223] (25.2 g) in
dioxane (250 mL) at 0 °C, was added N,N-di-isopropylethylamine (29 mL, 167
mmol) and di-tert-butyl dicarbonate (31.8 g, 146 mmol). The reaction mixture
was stirred for 1 hour then allowed to warm to room temperature and stirred
overnight. The solution was concentrated under reduced pressure. The mixture
was taken up in ethyl acetate (500 mL) and washed with a 1 M citric acid
solution (500 mL). The phases were separated and the aqueous phase was
further extracted with ethyl acetate (3 x 500 mL). The combined organic
extracts were washed with a saturated sodium bicarbonate solution (500 mL)
and a saturated sodium chloride solution (500 mL), dried over magnesium
sulfate and concentrated under 143 reduced pressure to give the Boc protected
methyl ester [224] as a yellow oil without the need for further purification
(31.3 g, 93%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 4.48
-4.44 (1H, m, 4-H), 4.43-4.37 (1H, m, 2-H), 3.73 (3H, s, CO2CH3), 3.63-3.43
(2H, m, 5-H), 2.28 (1H, m, 3-H), 2.08 (1H, m, 3-H), 1.45 and 1.41 (9H, 2 x s,
C(CH3)3). δC (125 MHz, CDCl3) (Doubling and broad peaks as a result of
rotamers) 173.6 and 173.4 (CO2CH3), 153.9 (N-C=O), 80.3 and 80.2
(C(CH3)3), 70.1 and 69.3 (C-4), 57.9 and 57.4 (C-2), 54.6 (C-5), 52.1 and 51.9
(CO2CH3), 39.0 and 38.4 (C-3), 28.3 and 28.2 (C(CH3)3). IR. 3435. 2928,
1809, 1737, 1658, 1419. cm-1; HRMS (ESI) [M+Na] m/z calcd C11H19NO5Na
268.1161, found 268.1146. Spectroscopic data identical to literature values.90
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(2S,4R)-4-Methanesulphonyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-
butyl-ester-2-methyl ester [225]
To a stirred solution of (2S,4R)-4-hydroxy-pyrrolidine-1,2-dicarboxylic acid 1-
tert-butyl ester 2-methyl ester [224] (177g, 720 mmol) and triethylamine (100
mL, 790 mmol) in dichloromethane (1200 mL) at 0 °C, was added
methanesulfonyl chloride (82.67 mL, 790 mmol) and 4-
dimethylaminopyridine (8.82 g, 72 mmol). The reaction mixture was allowed
to warm up to room temperature and stirred for 24 hours, before cooling to 0
°C and adding a saturated aqueous solution of ammonium chloride (1200 mL).
The phases were separated and the aqueous phase was extracted with ethyl
acetate (3 x 600 mL). The combined organic extracts were washed with a
saturated aqueous solution of sodium bicarbonate solution (500 mL) and a
saturated sodium chloride solution (500 mL), dried over magnesium sulfate
and concentrated under reduced pressure to reveal [225] as an orange
crystalline solid. (223.94 g, 96%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 5.26
(1H, m, 4- H), 4.49-4.39 (1H, m, 2-H), 3.87-3.77 (2H, m, 5-H), 3.75 (3H, s,
CO2CH3), 3.05 (3H, s, SO2CH3), 2.62 (1H, m, 3-H), 2.27 (1H, m, 3-H), 1.47
and 1.43 (9H, 2 x s, C(CH3)3). δC (125 MHz, CDCl3) (Doubling and broad
peaks as a result of rotamers) 174.7 and 172.6 (CO2CH3), 153.3 and 150.6 (N-
C=O), 80.8 (C(CH3)3), 78.1 and 77.8 (C-4), 57.4 and 57.0 (C-2), 52.4 and 52.2
(CO2CH3), 52.4 and 52.1 (C-5), 38.7 and 38.6 (SO2CH3), 37.4 and 36.2 (C-3),
28.2 and 28.1 (C(CH3)3). IR 2971, 1746, 1697, 1438, 1398, 1351, 1213, cm-1;
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HRMS (ESI) calcd C12H21NO7SNa [M+Na] m/z 346.0931, found 346.0918.
Spectroscopic data identical to literature values.90
(S)-2,5-dihydro-pyrrole-1,2-dicarboxylic acid 1-tert-butyl ester 2-ethyl
ester [227]
To a stirred suspension of diphenyl diselenide (19.2 g, 62 mmol) in ethanol
(300 mL) at 0 °C was added sodium borohydride (5.1 g, 135 mmol) portion
wise. The reaction mixture was allowed to warm to room temperature and
stirred for 1 hour, before re-cooling to 0 °C and adding (2S,4R)-4-
methanesulphonyloxy-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl-ester 2-
methyl ester [225] (36.2 g, 112 mmol) in ethanol (100 mL). The reaction
mixture was stirred for 24 hours at room temperature before being heated to
reflux and stirred for 6 hours. The solution was concentrated under reduced
pressure to reveal a yellow crystalline solid. The solid was dissolved in diethyl
ether (400 mL) and washed with water (250 mL). The phases were separated
and the aqueous phase was further extracted with diethyl ether (3 x 200 mL).
The combined organic extracts were washed with a saturated sodium chloride
solution (250 mL), dried over magnesium sulfate and concentrated under
reduced pressure to give the crude phenyl selenide [226] as a orange/brown oil
(42.3 g 95%).
To a vigorously stirred solution of the resulting crude phenyl selenide [226]
(42.3 g) and pyridine (16.8 mL, 212 mmol) in dichloromethane (725 mL) at -
78 °C was added a 35 wt.% hydrogen peroxide solution (51.6 mL, 530 mol)
dropwise over 1 hour. The reaction mixture was allowed to warm to room
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temperature and stirred for 10 hours, before adding a saturated ammonium
chloride solution (350 mL). The phases were separated and the aqueous phase
was further extracted with dichloromethane (3 x 200 mL). The combined
organic extracts were washed with a saturated ammonium chloride solution
(500 mL) and a saturated sodium chloride solution (500 mL), dried over
magnesium sulfate and concentrated under reduced pressure to reveal a brown
oil residue (32.1 g). The resulting residue was subjected to flash column
chromatography on silica, eluting with 20% diethyl ether/petrol, then 50%
diethyl ether/petrol to give [227] as a orange/brown oil (9.7 g, 38%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers)
5.99-5.93 (1H, m, 4-H), 5.75-5.70 (1H, m, 3-H), 5.05-4.93 (1H, m, 2-H), 4.31-
4.15 (4H, m, 5-H and OCH2CH3) 1.49 and 1.44 (9H, 2 x s, C(CH3)3), 1.28-
(3H, m, OCH2CH3). δC (125 MHz, CDCl3) (Doubling and broad peaks as a
result of rotamers) 170.5 (CO2Et3), 153.4 (N-C=O), 129.2 and 129.1 (C-4),
124.8 and 123.6 (C-3), 80.1 and 80.0 (C(CH3)3), 66.6 and 66.3 (C-2), 61.1
(OCH2CH3), 53.4 and 53.2 (C-5), 28.4 and 28.2 (C(CH3)3), 14.2 and 14.1
(CO2CH3). IR 2976, 1752, 1701, 1392, 1366, 1171. cm-1; HRMS (ESI) calcd
C12H19NO4Na [M+Na] m/z 264.1212, found 264.120.  [α]D24 = -235.7. (C 1.2
CHCH3) Spectroscopic data identical to literature values.90
(2S,4S)-1-tert-butyl-2-methyl-4-iodopyrrolidine-1,2-dicarboxylate [229]
To a vigorously stirred solution of (2S,4R)-4-hydroxy-pyrrolidine-1,2-
dicarboxylic acid 1-tert-butyl ester 2-methyl ester [224] (34.52 g, 141 mmol)
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in toluene (300 mL) and acetonitrile (150 mL) at 0 °C, was added triphenyl
phospine (108.11g, 412 mmol) and iodine (108.24g, 426 mmol). The reaction
mixture was left to stir for 1 hour before imidazole (56.58g, 832 mmol) was
added portion wise over 10 minutes. The reaction mixture was allowed to
warm to room temperature and stirred for 72 hours. The reaction mixture was
filtered to remove the undesired solid and the filtrate was concentrated under
reduced pressure. Diethyl ether (4 x 150 mL) was added and the resultant
triphenyl phospine oxide precipitate was removed via filtration. The combined
filtrates were was washed with a solution of sodium thiosulphate and the
aqueous phase separated and further extracted with Diethyl ether (2 x 150
mL). The combined organic extracts were dried over magnesium sulfate and
concentrated under reduced pressure to give a dark orange viscous oil. The
resultant oil was subjected to flash column chromatography on silica, eluting
with 30% diethyl ether/hexanes to give the iodo-pyrrolidine [229] as a white
crystalline solid (40.8 g, 82%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers)
4.32-4.21 (1H, dt, J 7.7 and 40.4 Hz, 2-H), 4.12-4.02 (2H, m, 3-H, 5-Ha), 3.75
(3H, s, CO2CH3), 3.66 (1H, m, 5-Hb), 2.86 (1H, m, 3- Ha), 2.34 (1H, m, 3- Hb),
1.46 and 1.41 (9H, 2 x s, C(CH3)3), δC (125 MHz, CDCl3) (Doubling of peaks
as a result of rotamers) 172.03 (CO2CH3), 154.06 (N-C=O), 80.69 (C(CH3)3),
59.14 and 58.56 (C-2), 56.98 and 56.59 (C-5), 52.36 and 52.17 (OCH3), 42.84
and 41.87 (C-3), 28.31 and 28.18 (C(CH3)3), 12.68 and 11.90 (C-4) IR.
2978.84, 1732.92, 1686.18, 1394.29, 1152.04. cm-1; HRMS (ESI) C11H19INO4
[M+H] m/z calcd 356.0353. found 356.0352. Mp 63oC. [α]D22 = -23.7. (C 1.0
CHCH3) TLC, (50% Et2O/Hexanes) Rf = 3.2. Spectroscopic data identical to
literature values.124
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(S)-tert-butyl-2-methyl-1H-pyrrole-1,2-(2H,5H)-dicarboxylate [231]
To a stirred solution of the iodo-methyl ester [229] (11.58g, 33 mmol) in
toluene (150 mL) was added 1,8-diazabicyclo-[5.4.0]-undec-7-ene (5.36 mL,
36 mmol). The reaction mixture was heated to 85oC for 24 hours. The reaction
mixture was filtered to remove the undesired precipitate and the filtrate was
concentrated under reduced pressure to give a viscous orange oil as the crude
product. The resultant oil was subjected to flash column chromatography on
silica, eluting with 5% ethyl acetate/hexanes to give a mixture of stereoisomers
as a clear orange oil for the desired product and a clear yellow/green oil as the
undesired product in an 8:1 ratio in favour of [231].
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers)
5.98-5.91 (1H, m, 4-H), 5.74-5.68 (1H, m, 3-H), 5.02-4.93 (1H, m, 2-H), 4.28-
4.16 (2H, m, 5-H), 3.72,3.71 (3H, 2 x s, CO2CH3), 1.46 and 1.41 (9H, 2 x s,
C(CH3)3), δC (125 MHz, CDCl3) (Doubling of peaks as a result of rotamers)
171.03 and 170.71 (CO2CH3), 153.82 and 153.31 (N-C=O), 129.34 and 129.31
(C-4) 124.79 and 124.62 (C-3) 80.13 and 80.09 (C(CH3)3), 66.53 and 66.17
(C-2), 53.46 and 53.22 (C-5), 52.21 and 52.08 (OCH3), 28.37 and 28.24
(C(CH3)3). IR. 2975, 1753, 1701, 1392, 1365, 1253, 1171, 1123. cm-1; HRMS
(ESI) calcd C11H17NO4Na [M+Na] m/z 250.1055. found 250.1050. Mp 63oC.
[α]D26.8 = -67.024. (C 1.15 MeOH). TLC, (25% EtOAc/Hexanes) Rf = 0.29.
Spectroscopic data identical to literature values.124
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(S)-tert-butyl-2-(hydroxymethyl)-2,5-dihydro-1H-pyrrole-1-carboxylate
[228]
To a stirred solution of (S)-tert-butyl-2-methyl-1H-pyrrole-1,2-(2H,5H)-
dicarboxylate [231] (9.4 g, 41 mmol) in anhydrous tetrahydrofuran (77 mL)
and anhydrous methanol (39 mL) at 0°C was added portion wise sodium
borohydride (4.7 g, 124 mmol). The reaction mixture was stirred at 0°C for 1
hour, warmed to room temperature and stirred for a further 24 hours. The
solution was cooled to 0°C and washed with a saturated solution of ammonium
chloride (115 mL). The organic portion was removed under reduced pressure
and the remaining aqueous phase was filtered through celite and washed with
ethyl acetate (2 x 120 mL). The phases were separated and the aqueous portion
was further washed with ethyl acetate (3 x 200 mL). the combined organic
fractions were dried over magnesium sulfate and concentrated under reduced
pressure to reveal a yellow/orange oil residue (7.1 g). The resulting residue
was subjected to flash column chromatography on silica, eluting with 60%
diethyl ether/hexane to give [228] as a pale yellow oil (7.2 g, 67%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 5.83
(1H, br s, 4-H), 5.64 (1H, br s, 3-H), 4.72 (1H, br s, 2-H), 4.20 (1H, br m, J
15.1 Hz, 5-H), 4.11-4.06 (1H, m, 5-H), 3.78 (1H, dd, J 2.3 and 11.4 Hz,
CH2OH), 3.59 (1H, m, CH2OH), 1.49 (9H, s, C(CH3)3). δC (125 MHz, CDCl3)
(Doubling of peaks as a result of rotamers) 156.4 (N-C=O), 126.8 (C-3), 126.8
(C-4), 80.4 (C(CH3)3), 67.4 and 67.2 (C-2), 67.0 (C-5), 54.1 (CH2OH), 28. 4
(C(CH3)3). IR. 3416, 2974, 2930, 2867, 1696, 1672, 1397, 1365. cm-1; HRMS
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(ESI) m/z calcd C10H17NO3Na [M+Na] 222.1101, found 222.1092. [α]D26.9 = -
342.97. (C 0.85 MeOH). TLC, (25% EtOAc/Hexanes) Rf = 0.20.
Spectroscopic data identical to literature values.22,31
(S)-5,7a-dihydro-1H-pyrrolo[1,2-c]oxazol-3-one [221]
To a stirred solution of (S)-tert-butyl-2-(hydroxymethyl)-2,5-dihydro-1H-
pyrrole-1-carboxylate [228] (4.9 g, 24 mmol) in dichloromethane (50 mL) at
0°C was added (diethylamino) sulfur trifluoride (4.23 mL, 32 mmol) in
dichloromethane (25 mL) dropwise. The reaction mixture was allowed to
warm to room temperature and stirred for 16 hours. The reaction was
quenched with sodium bicarbonate (100 mL) and the phases separated. The
aqueous phase was further extracted with dichloromethane (3 x 100 mL). The
combined organic extracts were dried over magnesium sulfate and
concentrated under reduced pressure to reveal an orange/brown oil residue.
The resulting residue was subjected to flash column chromatography on silica,
eluting with 40% ethyl acetate/hexane to give [221] as a pale yellow/orange oil
(1.8 g, 59%).
δH (500 MHz, CDCl3) 6.00-5.99 (1H, m, 7-H), 5.87-5.86 (1H, m, 6-H), 4.68
(1H, m, 5-H), 4.56 (1H, dd app. t, J 8.7 Hz, 4-H), 4.34-4.31 (1H, m app d, J
15.5 Hz, 8-H), 4.19 (1H, dd, J 5.1 and 8.7, 4-H), 3.78-3.75 (1H, m app d, J
15.5 Hz,, 8-H). δC (75 MHz, CDCl3) 163.25 (C-2), 130.79 (C-7), 129.03 (C-6),
68.71 (C-4), 64.65 (C-5), 54.79 (C-8). IR. 2920, 2878, 1738, 1384, cm-1;
HRMS (ESI) m/z calcd C6H7NO2Na [M+Na] 148.0369, found 148.0370. TLC,
119
(60% EtOAc/Hexanes) Rf = 0.24. Spectroscopic data identical to literature
values.22,31
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3.3. Synthesis of anisomycin [274]
(1aS,1bR,5aR)­Tetrahydro­1,3­dioxa­4a­aza­cyclopropa[α]pentalen­4­one
[234]
(1aR,1bS,5aR)­Tetrahydro­1,3­dioxa­4a­aza­cyclopropa[α]pentalen­4­one
[236]
To a vigorously stirred suspension of (S)-5,7a-dihydro-1H-pyrrolo[1,2-
c]oxazol-3-one [221] (717 mg, 5.7 mmol), ethyl acetate (38 mL), water (28
mL), sodium bicarbonate (2.41 g 29mmol) and acetone (4.21 mL) at room
temperature was added Oxone® (4.23 g, 6.9 mmol) in water (38 mL) dropwise
over 2 hours. The reaction mixture was left to stir for 1 hour before being
quenched with saturated sodium chloride (50 mL). The phases were separated
and the aqueous phase was further extracted with ethyl acetate (4 x 60 mL).
The combined organic extracts were dried over magnesium sulfate and
concentrated under reduced pressure. The resulting residue was subjected to
flash column chromatography on silica, eluting with 80/20% ethyl acetate/
hexane to give [234] as a white solid (661 mg, 81.6%).
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δH (500 MHz, CDCl3) 4.53 (1H, dd, app. t, J 8.3 Hz, 4-H), 4.47 (1H, dd, J 9.0
and 3.95 Hz, 4-H), 3.97 (1H, dd, J 8.4 and 4.0 Hz, 5-H), 3.95 (1H, d, J 13.4
Hz, 8-H), 3.70 (1H, d, J 2.8, 7-H), 3.64 (1H, d, J 2.8, 6-H), 3.14 (1H, d, J 13.3
Hz, 8-H). δC (125 MHz, CDCl3) 162.8 (C-2), 64.5 (C-4), 58.2 (C-5), 55.5 (C-
7), 55.3 (C-6), 48.3 (C-8),. IR. 3680.93, 2973.14, 2865.69, 1733.00, 1410.81,
cm-1; HRMS (ESI) m/z calcd C6H7NO3Na [M+Na] 164.0318, found 164.0314.
[α]D23 = -8.9. (C 1.90 CH2Cl2). Mp 59-63oC. TLC, (100% EtOAc) Rf = 0.36.
(1aR,1bS,5aR)­Tetrahydro­1,3­dioxa­4a­aza­cyclopropa[α]pentalen­4­one
[236]
δH (500 MHz, CDCl3) 4.57 (1H, dd, app. t, J 8.3 Hz, 4-H), 4.23 (1H, dd, app. t,
J 7.4 Hz, 4-H), 4.19 (1H, dd, app. t, J 8.1 Hz, 5-H), 3.97 (1H, dd, app. t, J 2.6
Hz, 7-H), 3.89 (1H, dd, J 13.2 and 2.6 Hz, 8-H), 3.71 (1H, d, J 2.74 Hz, 6-H),
3.35 (1H, d, J 13.1 Hz, 8-H). δC (125 MHz, CDCl3) 148.4 (C-2), 64.7 (C-4),
61.54 (C-6), 61.0 (C-7), 60.0 (C-5), 50.1 (C-8). IR. 2949, 1735, 1405, 1354,
1304, 1251, 1202, 1166, 1071. cm-1; HRMS (ESI) m/z calcd C6H7NO3Na
[M+Na] 164.0318,  found 164.0319. [α]D25.4 = +13.273. (C 0.6 MeOH). TLC,
(100% EtOAc) Rf = 0.36.
(6S,7S,7aR)-6-benzyloxy)-7-hydroxy-tetrahydropyrrol[1,2-c]-oxazol-
3(1H)-one [240]
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(6S,7S,7aR)-7-Benzyloxy)-6-hydroxy-tetrahydropyrrol[1,2-c]-oxazol-
3(1H)-one [241]
To a stirred solution of (1aS,1bR,5aR)-Tetrahydro-1,3-dioxa-4a-aza-
cyclopropa[α]pentalen­4­one [234] (100 mg, 7 mmol) in dry benzyl alcohol
(2.5 mL, 237mmol) at 0°C was added (diethyloxonio)trifluoroborate (0.89 mL,
7 mmol) dropwise and the reaction mixture was allowed to warm to room
temperature and stirred for 16 hours. The reaction was quenched with sodium
bicarbonate (50 mL) and the phases separated. The aqueous phase was further
extracted with diethyl ether (4 x 100 mL). The combined organic extracts were
dried over magnesium sulfate and concentrated under reduced pressure. The
resulting crude product was subjected to flash column chromatography on
silica, eluting with 20% ethyl acetate/hexane and increasing to 40% ethyl
acetate/hexane to give [240] and [241] as a clear needle type crystalline solid
(5.23 g, 71%) in an inseparable mixture of regioisomers in an (8:1) ratio in
favour of [240].
δH (500 MHz, CDCl3) 7.38 (3H, m, 13-H, 14-H,) 7.36 (2H, m, 12-H,) 4.56
(2H, m, 10-H) 4.52 - 4.46 (2H, m, 4-H), 4.14 (1H, m, 6-H), 4.12 (1H, m, 5-H),
4.11 (1H, m, 7-H), 3.90 (1H, dd, J 12.6 and 5.3 Hz, 8-H), 3.22 (1H, J 12.3 Hz,
8-H), δC (125 MHz, CDCl3) 162.58 (C-2), 137.55 (C-11), 128.62 (C-14),
128.54 (C-13), 127.63 (C-12), 84.85 (C-7), 73.14 (C-5), 62.72 (C-4), 62.12 (C-
6), 50.92 (C-8). TLC, (EtOAc) Rf = 0.48. IR. 3377.72, 2960.93, 1714.96,
1399.60, 1255.73 cm-1; HRMS (ESI) m/z calcd C13H16NO4 [M+H] 250.1074,
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found 250.1070. HRMS (ESI) m/z calcd C13H15NO4Na [M+Na] 272.0893,
found 272.0892. [α]D23 = -10.249. (C 0.1 CHCl3) M.P = 148.8 – 149.4oC.
(6S,7S,7aR)-7-Benzyloxy)-6-hydroxy-tetrahydropyrrol[1,2-c]-oxazol-
3(1H)-one [241]
δH (500 MHz, CDCl3) 7.33 (1H, m, 14-H,) 7.31 (2H, m, 13-H,) 7.30 (2H, m,
12-H,) 4.66 (2H, m, 10-H) 4.51 (1H, m, 4-H), 4.54 (1H, m, 7-H), 4.19 (1H, m,
4-H), 3.91 (1H, m, 5-H), 3.77 (1H, s, 6-H), 3.73 (1H, m, 8-H), 3.37 (1H, m, 8-
H), δC (125 MHz, CDCl3) 163.61 (C-2), 133.74 (C-11), 128.16 (C-14), 128.00
(C-13), 127.78 (C-12), 88.57 (C-6), 75.79 (C-7), 72.47 (C-10), 67.71 (C-4),
63.99 (C-5), 54.01 (C-8). TLC, (EtOAc) Rf = 0.48. IR. 3377.72, 2960.93,
1714.96, 1399.60, 1255.73 cm-1 HRMS (ESI) m/z calcd C13H16NO4 [M+H]
250.1074, found 250.1070. HRMS (ESI) m/z calcd C13H15NO4Na [M+Na]
272.0893, found 272.0892. M.P = 148.8 – 149.4oC.
(2R,3S,4S)-4-(benzyloxy)-2-(hydroxymethyl)-pyrrolidin-3-ol [242]
To a stirred solution of (6S,7S,7aR)-6-Benzyloxy)-7-hydroxy-tetrahydropyrrol-
[1,2-c]-oxazol-3(1H)-one [240] (1 g, 4 mmol) in ethanol (50 mL) was added
lithium hydroxide (0.5 g, 20 mmol) and the reaction mixture was subject to
reflux for 5days. The solution was filtered through celite to remove the
undesired precipitate and washed with cold dichloromethane (4 x 120 mL). The
solution was concentrated under reduced pressure to give a yellow viscous oil.
The oil was taken up in ethyl acetate and heated to 80oC and left to cool to give
a white crystalline solid [242] (0.85 g, 95%)
124
δH (500 MHz, CD3OD) 7.34 (1H, m, 8-H), 7.33 (2H, m, 9-H), 7.27 (2H, m, 10-
H), 4.81 (2H, br s,, OH), 4.57 (2H, dd, J 11.65 and 17.52 Hz, 6-H), 4.24 (1H,
d, J 3.13 Hz, 3-H), 3.93 (1H, m, 4-H), 3.78 (2H, ddd, J 38.61, 11.19 and 6.05
Hz, 11-H), 3.33 (1H, m, 5-Ha), 3.27 (1H, m, 2-H), 2.90 (1H, m, 5-Hb), δC (125
MHz, CD3OD) 138.14 (C-7), 127.95 (C-8), 127.42 (C-9), 127.27 (C-10), 85.01
(C-4), 74.52 (C-3), 71.02 (C-6), 62.22 (C-2), 59.72 (C-11), 49.43 (C-5). IR.
3288, 2900, 1457, 1443, 1301, 1063. cm-1 HRMS (ESI) m/z calcd C12H18NO3
[M+H] 224.1287,  found 224.1276.  [α]D27.4 = -21.330. (C 0.25 MeOH). TLC,
(20/80% MeOH/CH2Cl2) Rf = 0.24. M.P. = 114.4-115.7oC.
(2R,3S,4S)-benzyl-4-(benzyloxy)-3-hydroxy-2-(hydroxymethyl)pyrrolidin-
carboxylate [243]
To a stirred solution of (2R,3S,4S)-4-(benzyloxy)-2-(hydroxymethyl)-
pyrrolidin-3-ol [242] (0.7 g, 3 mmol) in acetone (0.45 mL) and water (6 mL) at
0°C was added benzyl chloroformate (25 mL) and sodium carbonate (0.19 g, 2
mmol). The reaction mixture was allowed to warm to room temperature and
left for 2 hours. The organic solvent was removed under reduced pressure and
the residue taken up in ethyl acetate and washed in 10% citric acid, aqueous
sodium bicarbonate and aqueous sodium chloride successively. The combined
organic extracts were dried over magnesium sulfate and concentrated under
reduced pressure to give a clear dark orange/brown viscous oil. The resulting
crude product was subjected to flash column chromatography on silica, eluting
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with 50% ethyl acetate/hexane to give [243] as a clear viscous pale yellow oil
(1.01 g, 90%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.34
(2H, m, 8-H), 7.33 (2H, m, 9-H), 7.32 (2H, m, 15-H), 7.30 (2H, m, 16-H), 7.29
(1H, m, 10-H), 7.28 (1H, m, 17-H), 5.12 (2H, m, 6-H), 4.55 (2H, m, 13-H),
4.37 (1H, m, 2-H), 3.94 (1H, m, 3-H), 3.92 (2H, m, 11-H), 3.68 (1H, m, 4-H),
3.68-3.55 (2H, m, 5-H). δH (500 MHz, Tol-d8 90oC) 7.27 (2H, m, 8-H), 7.25
(2H, m, 9-H), 7.20 (2H, m, 15-H), 7.19 (2H, m, 16-H), 7.17 (1H, m, 10-H),
7.15 (1H, m, 17-H), 5.10 (2H, m, 6-H), 4.35 (2H, m, 13-H), 4.11 (1H, m, 2-H),
3.97 (2H, m, 11-H), 3.85 (1H, m, 3-H), 3.76 (1H, m, 4-H), 3.60 (2H, m, 5-H).
δC (125 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers)
156.26 (C-12), 137.69 (C-13), 136.34 (C-7), 128.53 (C-8), 128.49 (C-9),
128.09 (C-15), 127.88 (C-16), 127.81 (C-10), 127.61 (C-17), 81.38 (C-3),
75.64 (C-2), 71.59 (C-13), 67.24 (C-6), 61.45 (C-11), 55.19 (C-4), 50.15 (C-
5). IR. 3377.70, 2941.83, 1673.03, 1497.46, 1453.78, 1416.37, 1354.61,
1204.15/ cm-1; HRMS (ESI) m/z calcd C20H23NO5Na [M+Na] 380.1468, found
380.1471. [α]D26.1 = -44.629. (C 1.35 MeOH). TLC, (50% EtOAc/Hexanes) Rf
= 0.17.
benzyl­7­(benzyloxy)­2,2­dioxohexahydro­1,3,2λ6,­5­[1,3,2λ6]-dioxathiino-
[5,4-b]-pyrrole-5-carboxylate [249]
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To a stirred solution of (2R,3S,4S)-benzyl-4-(benzyloxy)-3-hydroxy-2-
(hydroxymethyl)pyrrolidin-carboxylate [243] (0.3 g, 0.84 mmol) in carbon
tetrachloride (20 mL) at 0°C was added dropwise thionyl chloride (0.095 mL).
The reaction mixture was refluxed for 30 minutes and allowed to cool to room
temperature before re-cooling to 0°C. To the reaction mixture was further
added acetonitrile (20 mL), ruthenium (III) chloride (0.0002 g, 0.8 mmol),
sodium meta periodite (0.27 g, 1.26 mmol) and water (25 mL). The reaction
mixture was allowed to warm to room temperature and left to stir for 1 hour.
The reaction mixture was taken up in diethyl ether (200 mL) and the phases
separated. The organic phase was washed successively in aqueous sodium
bicarbonate and aqueous sodium chloride and the combined organic extracts
were dried over magnesium sulfate and concentrated under reduced pressure to
give a dark brown viscous oil. The resulting crude product was subjected to
flash column chromatography on silica, eluting with 50% diethyl ether/hexane
to give [249] as a viscous orange oil (0.27 g, 77%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.36
(4H, m, 8-H, 15-H), 7.35 (4H, m, 9-H, 16-H), 7.26 (2H, m, 10-H, 17-H), 5.51
(1H, d, J 12.72 Hz, 11-H), 5.26 (1H, m, 3-H), 5.16 (2H, s, 13-H), 4.94 (1H, d, J
12.37 Hz, 11-H), 4.57 (2H, s, 6-H), 4.06 (1H, m, 4-H), 4.03 (1H, m, 2-H), 3.85
(1H, d, J 12.45 Hz, 5b-H), 3.71 (1H, dd, J 12.31 and 3.68 Hz, 5a-H). δC (125
MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 155.62 (C-
12), 136.36 (C-14), 135.93 (C-7), 128.72 (C-15), 128.59 (C-8), 128.44 (C-16),
128.30 (C-9), 127.96 (C-17), 127.71 (C-10), 85.99 (C-3), 77.74 (C-4), 71.99
(C-11), 71.87 (C-6), 67.58 (C-13), 52.28 (C-2), 51.17 (C-5). IR. 3034.21,
2954.12, 1973.94, 1699.63, 1497.75, 1455.41, 1401.52, 1352.43, 1318.65,
1304.27, 1198.51. cm-1; HRMS (ESI) m/z calcd C21H23NSO7 [M+H] 442.0931,
found 442.940. TLC, (50% Et2O/Hexanes) Rf = 0.27.
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(6S,7S,7aR)-6-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-tetrahydro-
pyrrolo-[1,2-c]-oxazol-3(1H)-one [252]
To a stirred solution of (6S,7S,7aR)-6-benzyloxy)-7-hydroxy-tetrahydropyrrol-
[1,2-c]-oxazol-3(1H)-one [240] (1 g, 4 mmol) in dichloromethane (20 mL) at
0°C was added tert-butyldimethylsilyl trifluoromethane (1.4 mL, 6 mmol) and
2,6-lutidine (0.93 mL, 8 mmol). The reaction mixture was left for 2 hours
before being quenched with aqueous sodium bicarbonate followed by aqueous
sodium chloride. The combined organic extracts were dried over magnesium
sulfate and concentrated under reduced pressure to give a clear viscous pale
yellow oil. The resulting crude oil was subjected to flash column
chromatography on silica, eluting with 25% ethyl acetate/hexane to give [252]
as a fine white powder (1.15 g, 79%).
δH (500 MHz, CDCl3) 7.37 (2H, m, 12-H), 7.33 (2H, m, 13-H), 7.30 (1H, m,
14-H), 4.60 (1H, d, J 11.56 Hz, 10-Ha), 4.51 (1H, d, J 11.56 Hz, 10-Hb), 4.45
(1H, app t, J 8.33 Hz, 4-Ha), 4.30 (1H, dd, J 8.67 and 3.08 Hz, 4-Hb), 4.12 (1H,
dt, J 8.26 and 2.73 Hz, 5-H), 4.01 (1H, d, J 1.90 Hz, 6-H), 3.96 (1H, d, J 5.28
Hz, 7-H), 3.82 (1H, dd, J 12.23 and 5.28 Hz, 8-Ha), 3.24 (1H, d, J 12.57 Hz, 8-
Hb) 0.86(9H, s, 20-H, 21-H, 22-H), 0.08 (3H, s, 17-H), 0.04 (3H, s, 18-H). δC
(125 MHz, CDCl3) 162.39 (N-C=O C-2), 137.29 (C-11), 128.60 (C-12),
128.05 (C-13), 127.49 (C-14), 84.48 (C-7), 74.05 (C-6), 71.82 (C-10), 62.55
(C-4), 62.37 (C-5), 51.10 (C-8), 25.48 (C-16), 25.40 (C-20,21,22), -4.51 (C-
17), -5.07 (C-18). IR. 2957, 2928, 2858, 1744, 1394, 1244, 1224, 1188,. cm-1;
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TLC, (25% EtOAc/Hexanes) Rf = 0.52. cm-1; HRMS (ESI) m/z calcd
C19H29NSiO4Na [M+Na] 386.1758, found 386.1768. [α]D27.1 = -18.397. (C 2.3
CH2Cl2). TLC, (25% Et2O/Hexanes) Rf = 0.52. M.P. = 51.2-52.3oC.
(6S,7S,7aR)-6-(benzyloxy)-7-(tetrahydro-2H-pyran-2-yloxy)-tetrahydro-
pyrrolo[1,2-c]-oxazol-3(1H)-one [254]
To a stirred solution of (6S,7S,7aR)-6-Benzyloxy)-7-hydroxy-tetrahydropyrrol-
[1,2-c]-oxazol-3(1H)-one [240] (0.7 g, 2.8 mmol) in dichloromethane (40 mL)
at room temperature was added freshly prepared pyridinium p-toluenesulfonate
(0.045 g, 0.18 mmol) and 3,4-dihydro-2H-pyran (0.24 mL, 2.7 mmol). The
reaction mixture was left for 6 hours before being diluted with diethyl ether
and quenched with aqueous sodium bicarbonate followed by aqueous sodium
chloride. The phases were separated and combined organic extracts were dried
over magnesium sulfate and concentrated under reduced pressure to give a
clear viscous oil. The resulting crude oil was subjected to flash column
chromatography on silica, eluting with 40% ethyl acetate/hexane to give [254]
as a fine white crystalline solid (0.81 g, 87%).
δH (500 MHz, CDCl3) 7.39 (2H, m, 12-H), 7.37 (2H, m, 13-H), 7.32 (1H, m,
14-H), 4.66 (1H, m, 16-H), 4.60 (1H, m, 4-Ha), 4.57 (2H, s, 10-H), 4.46 (1H,
app t, J 8.53 Hz, 4-Hb), 4.22 (1H, dt, J 8.49 and 3.39 Hz, 6-H), 4.17 (1H, d, J
3.51 Hz, 5-H), 4.10 (1H, d, J 5.64 Hz, 7-H), 3.87 (1H, dd, J 12.62 and 5.52 Hz,
20-Ha), 3.81 (1H, m, 8-Ha), 3.54 (1H, m, 8-Hb), 3.25 (1H, d, J 12.75, 20-Hb),
1.79 (2H, m, 17-H), 1.67 (2H, m, 19-H), 1.53 (2H, m, 18-H). δC (125 MHz,
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CDCl3) 162.04 (N-C=O C-2), 137.25 (C-11), 128.56 (C-12), 128.05 (C-13),
127.61 (C-14), 96.73 (C-16), 81.72 (C-7), 76.30 (C-6), 71.80 (C-10), 63.17 (C-
8), 62.81 (C-4), 61.29 (C-5), 51.15 (C-20), 30.64 (C-17), 25.15 (C-19) 19.40
(C-18). IR. 2975, 2950, 2878, 1736, 1388. cm-1; HRMS (ESI) m/z calcd
C18H24NO5 [M+H] 334.1649, found 334.1657. TLC, (50% EtOAc/Hexanes) Rf
= 0.46. M.P. = 96.4-97.5oC.
((2R,3S,4S)-4-(benzyloxy)-3-(tetrahydro-2H-pyran-2-yloxy)pyrrolidin-2-
yl)methanol [257]
To a stirred solution of (6S,7S,7aR)-6-(benzyloxy)-7-(tetrahydro-2H-pyran-2-
yloxy)-tetrahydro-pyrrolo[1,2-c]-oxazol-3(1H)-one [254] (8 g, 24 mmol) in
ethanol (28 mL) was added lithium hydroxide (2.9 g, 120 mmol) and the
reaction mixture was subject to reflux for 5days. The solution was filtered
through celite to remove the undesired precipitate and washed with cold
dichloromethane (4 x 120 mL). The solution was concentrated under reduced
pressure to give a yellow viscous oil. The resultant crude oil was subjected to
flash column chromatography on silica, eluting with 10% methanol
/dichloromethane to give [257] as a clear viscous oil (6.3 g, 86%)
δH (500 MHz, CDCl3) 7.34 (1H, m, 8-H), 7.34 (2H, m, 9-H), 7.30 (2H, m, 10-
H), 4.82 (2H, br s, NH OH), 4.62 (1H, m, 14-H), 4.58 (2H, m, 12-H), 4.23 (2H,
s, 7-H), 3.96 (1H, m, 3-H), 3.81 (1H, m, 18-Ha), 3.79 (1H, m, 2-H), 3.76 (1H,
m, 4-H), 3.50 (1H, m, 5-Ha), 3.42 (1H, dd, J 12.74 and 4.47 Hz, 5-Hb), 3.24
(1H, d, J 12.44 Hz, 18-Hb), 1.79 (1H, m, 15-Ha) 1.70 (1H, m, 17-Ha) 1.53 (4H,
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m, 16-H, 15-Hb,17-Hb). δC (125 MHz, CDCl3) 137.61 (C-8), 128.41 (C-9),
127.84 (C-10), 127.81 (C-11), 100.91 (C-14), 82.48 (C-4), 81.49 (C-3), 71.47
(C-7), 63.20 (C-5), 62.52 (C-12) 59.57 (C-2), 49.10 (C-18), 30.63 (C-15) 25.14
(C-17), 19.59 (C-16). IR. 3229 (Br), 1540, 1418, 1308, 1261, 1202, 1111. cm-1;
HRMS (ESI) m/z calcd C17H26NO4 [M+H] 308.1856, found 308.1852. TLC,
(10% MeOH/CH2Cl2) Rf = 0.33.
(2R,3S,4S)-benzyl-4-(benzyloxy)-2-(hydroxymethyl)-3-(tetrahydro-2H-
pyran-2-yloxy)pyrrolidine-1-carboxylate [261]
To a stirred solution of ((2R,3S,4S)-4-(benzyloxy)-3-(tetrahydro-2H-pyran-2-
yloxy)pyrrolidin-2-yl)methanol [257] (10 g, 33 mmol) in acetone (15 mL) and
water (150 mL) at 0°C was added benzyl chloroformate (5.1 mL) and sodium
carbonate (2.07 g, 20 mmol). The reaction mixture was allowed to warm to
room temperature and left for 2 hours. The organic solvent was removed under
reduced pressure and the residue taken up in ethyl acetate and washed in 10%
citric acid, aqueous sodium bicarbonate and aqueous sodium chloride
successively. The combined organic extracts were dried over magnesium
sulfate and concentrated under reduced pressure to give a dark orange viscous
oil. The resulting crude product was subjected to flash column chromatography
on silica, eluting with 25% ethyl acetate/hexane to give [261] as a clear viscous
pale yellow oil (12.7 g, 88%).
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δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.36
(4H, m, 9-H, 24-H), 7.35 (4H, m, 10-H, 25-H), 7.30 (2H, m, 11-H, 26-H), 5.15
(2H, m, 22-H), 4.60 (1H, m, 14-H), 4.55 (2H, s, 7-H), 4.40 (1H, s, 3-H), 4.13
(1H, m, 4-H), 3.96 (1H, m, 2-H), 3.94 (2H, m, 5-H), 3.90 (1H, m, 18-Ha), 3.61
(2H, m, 12-H), 3.52 (1H, m, 18-Hb), 3.12 (2H, br s, NH, OH), 1.78 (1H, m, 15-
Ha), 1.72 (1H, m, 16-Ha), 1.53 (2H, m, 17-H), 1.51 (1H, m, 15-Hb), 1.51 (1H,
m, 16-Hb). δC (125 MHz, CDCl3) (Doubling and broad peaks as a result of
rotamers) 156.16 (C-20), 137.59 (C-23), 136.51 (C-8), 128.49 (C-24), 128.47
(C-9), 128.00 (C-25), 127.89 (C-10), 127.88 (C-26), 127.52 (C-11), 98.62 (C-
14), 79.37 (C-2), 78.85 (C-3), 71.44 (C-7), 66.15 (C-22), 63.77 (C-18) 61.85
(C-4), 61.79 (C-5), 50.11 (C-12), 30.85 (C-15), 25.06 (C-17), 20.02 (C-15). IR.
2939, 1691, 1415, 1351, 1201, 1074, 1033. cm-1; HRMS (ESI) m/z calcd
C25H31NO6Na [M+Na] 464.2044, found 464.2049. TLC, (50%
EtOAc/Hexanes) Rf = 0.21.
(2R,3S,4S)-benzyl 4-(benzyloxy)-2-(hydroxy(4-methoxyphenyl)methyl)-3-
(tetrahydro-2H-pyran-2-yloxy)pyrrolidine-1-carboxylate [267]
To a stirred solution of trifluoroacetic anhydride (0.5 mL, 3.5 mmol) in
dichloromethane (5 mL) at -78°C was added dropwise over 10 minutes
dimethyl sulfoxide (0.33 mL, 4.7 mmol) in dichloromethane (5 mL). The
132
reaction mixture was left to stir for 30 minutes. A solution of (2R,3S,4S)-
benzyl-4-(benzyloxy)-2-(hydroxymethyl)-3-(tetrahydro-2H-pyran-2-yloxy)-
pyrrolidine-1-carboxylate [261] (1 g, 2.3 mmol) in dichloromethane (10 mL) at
-78°C was added dropwise over 15 minutes and the reaction mixture was left to
stir at -78°C for 2 hours. A further solution of triethylamine (0.93 mL, 7 mmol)
in dichloromethane (10 mL) was added dropwise over 15 minutes and the
reaction mixture was left for a further 1 hour before being allowed to warm to
room temperature over 2 hours. The reaction was quenched with aqueous
sodium bicarbonate and washed with aqueous sodium chloride and extracted
with diethyl ether. The combined organic extracts were dried over magnesium
sulfate and concentrated under reduced pressure to give a dark brown oil. The
resulting crude aldehyde product [266] (0.6 g) was carried forward to the next
step without purification.
To a stirred solution of 4-iodoanisole (1.12, 5 mmol) in tetrahydrofuran (20
mL) at -78°C was added dropwise over 10 minutes 2.5M nbutyllithium (3.62
mL, 6.03 mmol) in tetrahydrofuran. The crude aldehyde [266] (2.0 g, 5 mmol)
in tetrahydrofuran (25 mL) was added dropwise over 20 minutes and the
reaction mixture was allowed to warm to room temperature and left to stir for 1
hour. The reaction mixture was quenched with aqueous sodium bicarbonate
and washed with aqueous sodium chloride and extracted with ethyl acetate.
The combined organic extracts were dried over magnesium sulfate and
concentrated under reduced pressure to give a viscous orange oil. The crude oil
was subjected to flash column chromatography on silica, eluting with 25%
ethyl acetate/hexane to give [267] as a clear viscous pale yellow oil (1.1 g,
44%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.37-
7.29 aromatic benzyl ether/carboxylate, (10H, m, 9-11-H and 24-26-H), 7.29
(2H, m, 28-H), 6.93 (2H, d, J 8.92, 29-H), 5.68 (1H, d, J 3.58,), 5.38 (1H, d, J
2.66, ), 4.82 (1H, m,), 4.69 (1H, m,), 4.57 (3H, m,) 4.47 (1H, d, J 5.20,), 4.28
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(1H, d, J 3.48,), 4.16 (1H, d, J 5.53,), 4.11 (1H, m,), 4.10 (1H, m,), 4.09 (1H,
m,), 3.92 (CH2, m,), 3.82 (3H, s, OMe), 3.89, 3.58 (CH2, m,), 3.81, 3.54 (CH2,
m,), 3.28 (CH2, m,), 1.51-1.87 Pyran (6H, m 15,16,17-H) δC (125 MHz,
CDCl3) (Doubling and broad peaks as a result of rotamers) 161.5, 159.9, 137.4,
137.1, 128.5, 128.4, 128.0, 127.9, 127.7, 127.6 (C-28), 127.5, 114.2 (C-29),
100.8, 97.0, 83.4, 81.9, 80.0, 76.1, 75.8, 71.9, 71.7, 68.7, 68.6, 63.3, 62.8, 55.3
(C-32), 51.1, 50.9, 30.7 (C-15), 25.2 (C-17), 19.5 (C-16), 19.1. IR. 2936, 2849,
1690, 1512, 1412, 1350, 1246, 1200. cm-1; TLC, (25% EtOAc/Hexanes) Rf =
0.23. HRMS (ESI) m/z calcd C32H37NO7Na [M+Na] 570.2462, found
570.2474.
(2S,3S,4S)-4-(benzyloxy)-2-(4-methoxybenzyl)pyrrolidin-3-ol [268]
To a vigorously stirred solution of (2R,3S,4S)-benzyl-4-(benzyloxy)-2-
(hydroxy(4-methoxyphenyl)methyl)-3-(tetrahydro-2H-pyran-2-yloxy)-pyrrol-
idine-1-carboxylate [267] (1 g, 1.8 mmol) in trifluoroacetic acid (10 mL) at
0°C was added trimethyl silane (2.4 mL) dropwise over 15 minutes. The
reaction mixture was allowed to warm to room temperature and left for 24
hours. The reaction mixture was taken up in ethyl acetate and washed with
aqueous sodium bicarbonate and aqueous sodium chloride successively
extracting with ethyl acetate. The combined organic extracts were dried over
magnesium sulfate and concentrated under reduced pressure to give a dark
orange viscous oil. The resultant crude oil was subjected to flash column
chromatography on silica, eluting with 10% methanol/dichloromethane to give
[268] as a clear viscous yellow oil (0.47 g, 81%).
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δH (500 MHz, CDCl3) 7.32 (2H, m, 16-H), 7.29 (2H, m, 17-H), 7.26 (1H, m,
18-H), 7.16 (2H, d, J 8.44 Hz, 8-H), 6.80 (2H, d, J 8.44 Hz, 9-H), 4.51 (1H, s,
14-H), 4.12 (1H, m, 4-H), 4.11 (1H, m, 3-H), 3.82 (1H, m, 2-H), 3.73 (3H, m,
12-H), 3.61 (1H, m, 5a-H), 3.17 (1H, m, 5b-H), 3.10 (1H, m, 6a-H), 2.97 (1H,
dd, J 13.94 and 7.26 Hz, 6b-H), δC (125 MHz, CDCl3) 158.77 (C-10), 136.83
(C-15), 130.02 (C-8), 128.57 (C-16), 128.13 (C-17), 127.76 (C-7), 127.75 (C-
18), 114.26 (C-9), 82.17 (C-4), 73.12 (C-3) ), 71.82 (C-14), 64.33 (C-2), 55.21
(C-12), 49.21 (C-5), 30.88 (C-6). IR. 2953, 1668, 1513, 1443, 1248, 1177,
1132, 1030. cm-1; HRMS (ESI) m/z calcd C19H24NO3 [M+H] 314.1751, found
314.1749. [α]D25.2 = -30.471. (C 0.2 MeOH). TLC, (10% MeOH/CH2Cl2) Rf =
0.37.
(2S,3S,4S)-benzyl4-(benzyloxy)-3-hydroxy-2-(4-methoxybenzyl)-
pyrrolidine-1-carboxylate [269]
To a stirred solution of (2S,3S,4S)-4-(benzyloxy)-2-(4-methoxybenzyl)-
pyrrolidin-3-ol [268] (0.7 g, 2.2 mmol) in acetone (10 mL) and water (2 mL) at
-10°C was added benzyl chloroformate (0.34 mL, 2.4 mmol) and sodium
carbonate (0.14 g, 1.3 mmol). The reaction mixture was allowed to warm to
room temperature and left for 2 hours. The organic solvent was removed under
reduced pressure and the residue taken up in ethyl acetate and washed in 10%
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citric acid, aqueous sodium bicarbonate and aqueous sodium chloride
successively. The combined organic extracts were dried over magnesium
sulfate and concentrated under reduced pressure to give a viscous yellow oil.
The resulting crude product was subjected to flash column chromatography on
silica, eluting with 25% ethyl acetate/hexane to give [269] as a clear viscous
pale yellow oil (0.78 g, 88%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.37
(1H, m, 25-H), 7.37 (4H, m, 17-H, 23-H), 7.33 (4H, m, 18-H, 24-H), 7.25 (2H,
m, 19-H, 25-H), 7.17 (2H, v br, 8-H), 6.79 (2H, m, 9-H), 5.17 (2H, m, 15-H),
4.46 (2H, m, H-21), 4.22 (1H, m, 4-H), 4.17 (1H, m, 3-H), 3.79 (3H, s, 12-H),
3.70 (1H, m, 2-H), 3.52 (2H, m, 5-H), 2.92 (2H, dd, J 13.20 and 8.61 Hz, 6-H),
δC (125 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers)
174.6 (C-13), 158.1 (C-10), 152.0 (C-16), 137.6 (C-22), 130.5 (C-8), 129.2 (C-
7), 128.4 (C-17), 128.4 (C-23), 127.9 (C-18), 127.8 (C-24), 127.6 (C-19),
127.6 (C-25), 113.8 (C-9), 80.8 (C-2), 74.9 (C-3), 71.6 (C-21), 66.8 (C-15)
61.2 (C-4), 48.9 (C-5), 55. 2 (C-12), 32.4 (C-6). IR. 2939, 1672, 1610, 1511,
1414, 1355, 1244, 1176, 1094. cm-1; HRMS (ESI) m/z calcd C27H29NO5Na
[M+Na]  470.1938,  found  470.1949.  [α]D26.2 = -28.566. (C 0.4 MeOH). TLC,
(25% EtOAc/Hexanes) Rf = 0.17.
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(2S,3S,4S)-benzyl-3-acetoxy-4-(benzyloxy)-2-(4-methoxybenzyl)-
pyrrolidine-1-carboxylate [273]
To a vigorously stirred solution of (2S,3S,4S)-benzyl4-(benzyloxy)-3-hydroxy-
2-(4-methoxybenzyl)-pyrrolidine-1-carboxylate [269] (0.6 g, 1.3 mmol) in
dichloromethane (10 mL) at 0°C was added pyridine (0.16 mL, 2.0 mmol) and
acetic anhydride (0.14 mL, 1.5 mmol) dropwise over 10 minutes. The reaction
mixture was allowed to warm to room temperature and left for 24 hours. The
reaction mixture quenched with 10% citric acid and washed with aqueous
sodium bicarbonate and aqueous sodium chloride successively extracting with
dichloromethane. The combined organic extracts were dried over magnesium
sulfate and concentrated under reduced pressure to give a dark orange viscous
oil. The resultant crude oil was subjected to flash column chromatography on
silica, eluting with 25% ethyl acetate/hexanes to give [273] as a clear viscous
pale orange oil (0.56 g, 84%).
δH (500 MHz, CDCl3) (Doubling and broad peaks as a result of rotamers) 7.38
(2H, m, 23-H), 7.37 (2H, m, 16-H),7.31 (2H, m, 24-H), 7.30 (2H, m, 17-H),
7.25 (2H, m, 25-H, 18-H), 6.99 (2H, br s, 8-H), 6.77 (2H, br d, 9-H), 5.17 (2H,
br s, 21-H), 5.07 (1H, dd ap t, J 4.82 Hz, 3-H), 4.51 (2H, m, 14-H), 4.43 (1H,
ddd, J 3.79, 5.68 and 9.73 Hz, 4-H), 3.79 (3H, s, 12-H), 3.79 (1H, s, 2-H), 3.60
(1H, br s, 5a-H), 3.47 (1H, dd ap t, J 5.49 and 11.99 Hz, 5b-H), 2.79 (2H, dd, J
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9.54 and 13.34 Hz, 6-H), 2.08 (1H, s, 28-H), δC (125 MHz, CDCl3) (Doubling
and broad peaks as a result of rotamers) 174.44 (C-19), 167.82 (C-27), 158.15
(C-10), 152.64 (C-22), 137 (C-15), 131.38 (C-7), 130.14 (C-8), 128.49 (C-23),
128.40 (C-16), 128.03 (C-24), 127.81 (C-17), 127.63 (C-18), 127.63 (C-25),
113.82 (C-9), 78.64 (C-2), 75.58 (C-3), 71.48 (C-14), 67.38 (C-21), 59.29 (C-
4), 55.18 (C-12), 49.49 (C-5), 32.91 (C-6), 20.88 (C-28). IR. 2941, 1739, 1699,
1611, 1511, 1454, 1409, 1356, 1230, 1108, 1035. cm-1; HRMS (ESI) m/z calcd
C29H31NO6Na [M+Na] 512.2049, found 512.2044. HRMS (ESI) m/z calcd
C29H31NO6K  [M+K]  528.1783,  found  528.1789.  [α]D21 = -26.129. (C 1.9
MeOH). TLC, (25% EtOAc/Hexanes) Rf = 0.3.
(2S,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidine-3-yl-acetate [274]
To a stirred solution of (2S,3S,4S)-benzyl-3-acetoxy-4-(benzyloxy)-2-(4-
methoxybenzyl)-pyrrolidine-1-carboxylate [273] (0.3 g, 6 mmol) in ethanol (10
mL) at room temperature under a hydrogen atmosphere was added 10%
palladium on carbon (0.073 g, 6 mmol). The reaction mixture was left to stir
for 3 days before the solution was filtered through paper and washed with cold
ethanol. The organic solvent was concentrated under reduced pressure to reveal
a clear viscous pale yellow oil. The resulting crude oil was subjected to flash
column chromatography on silica, eluting with 10% methanol/dichloromethane
to give [274] as a fine white powder (0.15 g, 93%).
δH (500 MHz, CDCl3) 7.08 (2H, d, J 8.69 Hz, 8-H), 6.81 (2H, d, J 8.69 Hz, 9-
H), 5.30 (1H, d, J 3.54 Hz, 3-H), 4.31 (1H, d, J 4.89 Hz, 4-H), 4.12 (1H, ddd, J
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15.54, 7.78 and 3.76, Hz, 2-H), 3.74 (3H, s, 12-H), 3.47 (1H, m, 5-Ha), 3.12
(1H, d, J 12.87, 5-Hb), 2.95 (1H, m, 5-Ha), 1.26 (3H, s, 16-H) δC (125 MHz,
CDCl3) 169.69 (C-14), 158.78 (C-10), 129.68 (C-8), 127.39 (C-7), 114.35 (C-
9), 77.51 (C-3), 73.47 (C-4), 61.61 (C-2), 55.20 (C-12), 51.06 (C-5) 31.54 (C-
6) 20.53 (C-16). IR. 3306.25, 2922.43, 1751.42, 1675.70, 1613.53, 1587.82,
1445.36, 1369.12, 1338.24, cm-1; HRMS (ESI) m/z calcd C14H20NO4 [M+H]
266.1387,  found  266.1384  [α]D21 = -2.844. (C 1.0 MeOH). TLC, (20%
MeOH/CH2Cl2) Rf = 0.15. M.P. = 178.7-179.5oC.
(2R,3S,4S)-4-hydroxy-2-(4-methoxybenzyl)pyrrolidin-3-yl acetate [1].
(-)-Anisomycin [1]
δH (500 MHz, CDCl3) 7.12 (2H, d, J 8.41 Hz, 8-H), 6.84 (1H, d, J 8.31 Hz, 9-
H), 4.72 (1H, d, J 5.09 Hz, 3-H), 4.19 (1H, m, 4-H), 3.79 (3H, s, 2-H), 3.74
(3H, s, 12-H), 3.51 (1H, m, 2-H), 3.43 (1H, dd, J 11.38 and 6.66 Hz, 5-Ha),
2.84 (1H, dd, J 13.78 and 6.14 Hz, 6-Ha), 2.79 (1H, m, 6-Hb), 2.74 (1H, m, 5-
Hb), 2.15 (3H, s, 16-H) δC (125 MHz, CDCl3) 171.57 (C-14), 158.19 (C-10),
131.03 (C-7), 129.69 (C-8), 114.01 (C-9), 82.45 (C-3), 77.94 (C-4), 61.11 (C-
2), 55.24 (C-12), 52.44 (C-5), 34.60 (C-6), 21.02 (C-16).
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